Dry age-related macular degeneration (includes geographic atrophy)

DRY_AMD

age-related macular degeneration: Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions not DRY_AMD_EARLY	520055
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE>=50 Registry filters: Hospital discharge: ICD-10 — H35.30 Hospital discharge: ICD-9 — 3625A Cause of death: ICD-10 — H35.30 Cause of death: ICD-9 — 3625A 2 out of 7 registries used, show all original rules.	8809
4. Check minimum number of events None	8809
5. Include endpoints None	8809
6. Filter based on genotype QC (FinnGen only)	8809

Control definitions (FinnGen only)

Control exclude: H7_RETINOPATHYDIAB, H7_RETINASEPAR, MACULA_NAS, H7_GLAUCPRIMOPEN, H7_GLAUCCLOSEPRIM, H7_GLAUCSECTRAUMA, H7_GLAUCSECINFLAM, H7_GLAUCSECDISEASE, H7_GLAUCSECDRUG, H7_GLAUCNAS
Control pre-conditions: DEATH_AGE>=50
Control conditions: not DRY_AMD_EARLY

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H35
Name in latin: Degeneratio maculae senilis atrophica

NAME	DRY_AMD
CONTROL_EXCLUDE	H7_RETINOPATHYDIAB\|H7_RETINASEPAR\|MACULA_NAS\|H7_GLAUCPRIMOPEN\|H7_GLAUCCLOSEPRIM\|H7_GLAUCSECTRAUMA\|H7_GLAUCSECINFLAM\|H7_GLAUCSECDISEASE\|H7_GLAUCSECDRUG\|H7_GLAUCNAS
CONTROL_PRECONDITIONS	DEATH_AGE>=50
CONTROL_CONDITIONS	!DRY_AMD_EARLY
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE>=50
CONDITIONS	!DRY_AMD_EARLY
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H3530
HD_ICD_9	3625A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H3530
COD_ICD_9	3625A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dry age-related macular degeneration (includes geographic atrophy) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	76411	48970	27076
Only index persons	68221	44279	23942
Unadjusted period prevalence (%)
Whole population	1.17	1.40	0.76
Only index persons	1.38	1.63	0.91
Median age at first event (years)
Whole population	79.61	80.34	78.29
Only index persons	79.38	80.14	77.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8809	4777	4032
Unadjusted period prevalence (%)	1.70	1.63	1.78
Median age at first event (years)	76.64	76.70	76.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7857: Matched controls
74245

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

10.0

323.0

2062

2552

XCK10

NOMESCO Finland

Photography of fundus of eye

5.0

323.0

1588

3580

Z96.1

ICD-10 Finland

Presence of intraocular lens

5.1

323.0

2816

7291

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.5

323.0

5101

25496

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

16.6

323.0

1915

1415

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

69.8

323.0

538

XCW99

NOMESCO Finland

Other investigative procedure of eye

7.4

323.0

2200

3716

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

24.5

323.0

2588

1456

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

4503599627370496.0

323.0

7830

268

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

144.1

323.0

721

H25.1

ICD-10 Finland

Senile nuclear cataract

2.9

323.0

4230

21189

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

8.5

323.0

1251

1623

XCD20

NOMESCO Finland

Photoangiography of eye

14.9

308.8

540

366

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.4

306.6

1770

5835

114

Kela drug reimbursment

Glaucoma

5.6

299.4

964

1820

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.4

293.2

4044

22623

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

129.1

287.9

315

S01ED51

ATC

timolol, combinations; ophthalmic

6.0

267.7

806

1393

H26.4

ICD-10 Finland

After-cataract

3.2

263.0

1650

5709

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.4

259.6

1485

4793

H25.8

ICD-10 Finland

Other senile cataract

2.8

230.5

1858

7502

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

20.3

226.0

351

171

S01EE01

ATC

latanoprost; ophthalmic

5.7

219.1

684

1226

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

209.0

3951

24108

XCK00

NOMESCO Finland

Perimetry

4.4

184.3

725

1663

H25.0

ICD-10 Finland

Senile incipient cataract

3.4

175.2

963

2947

H35.7

ICD-10 Finland

Separation of retinal layers

1750.6

174.8

173

XCH00

NOMESCO Finland

Eye pressure measurement

5.3

160.0

528

1001

H40.11

ICD-10 Finland

Low pressure glaucoma

53.9

159.7

195

S01EC04

ATC

brinzolamide; ophthalmic

8.6

153.9

353

405

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

4.9

142.5

498

1004

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

13.0

141.4

260

195

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

16.0

139.4

235

143

N02BE01

ATC

paracetamol; systemic, rectal

2.2

138.3

6706

54187

ZXA10

NOMESCO Finland

Bilateral

2.1

137.5

1941

10014

A98

ICPC

Health maint/preventive medicine

2.1

130.8

6697

54369

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

17.0

128.4

211

120

H3601, E113

ICD-10 Finland

+∞

125.7

123

H3600, E113

ICD-10 Finland

+∞

125.7

123

H40.0

ICD-10 Finland

Glaucoma suspect

3.3

118.3

661

2020

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

8.2

117.7

277

331

SPAT1263

SPAT

Sampling

1.7

113.0

3404

22651

S01ED01

ATC

timolol; ophthalmic

5.0

107.8

369

724

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

99.8

1040

4599

H40.9

ICD-10 Finland

Glaucoma, unspecified

24.0

99.2

145

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

34.0

98.2

131

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

17.4

97.8

159

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

10.8

97.3

195

175

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

96.2

5473

42794

S01EX03

ATC

6.8

92.1

244

348

J01DB01

ATC

cefalexin; oral

1.7

91.5

5751

45848

WX140

NOMESCO Finland

Parabulbar anesthesy

3.6

90.9

450

1247

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

86.0

3337

23231

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

408.7

84.3

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

17.6

81.7

132

SPAT1312

SPAT

General health counselling

1.7

80.8

2325

14849

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

5.3

80.4

259

474

CHD00

NOMESCO Finland

Laser trabeculoplasty

23.1

80.0

118

S01EC01

ATC

acetazolamide; systemic

7.2

78.9

200

268

S01EE05

ATC

tafluprost; ophthalmic

5.2

78.5

258

483

S01EC03

ATC

dorzolamide; ophthalmic

10.6

77.4

156

142

ZX198

NOMESCO Finland

Other local administration

7.5

77.4

191

246

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

77.3

2897

19809

SPAT1301

SPAT

No procedures

1.6

75.0

2755

18699

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

74.1

1280

6918

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

13.0

73.5

134

S01EE03

ATC

bimatoprost; ophthalmic

7.5

73.4

181

233

A02BC02

ATC

pantoprazole; systemic

1.5

72.6

4917

38539

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

72.5

1952

12154

WX110

NOMESCO Finland

Local anesthesy

1.5

71.2

4147

31317

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

70.4

2369

15656

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

14.3

69.3

121

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

69.2

3650

26868

H36.00

ICD-10 Finland

Diabetic background retinopathy

29.3

68.9

AA1AD

NOMESCO Finland

CT of head and brain

1.6

67.6

2231

14630

SPAT1310

SPAT

Counselling related to known health issue

1.6

67.4

2371

15806

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.7

65.7

1872

11783

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

64.7

727

3290

S01EE04

ATC

travoprost; ophthalmic

5.8

64.4

191

317

SPAT1325

SPAT

Vaccination

1.5

64.3

3090

22133

H36.01

ICD-10 Finland

Diabetic maculopathy

50.2

64.3

S01EC54

ATC

brinzolamide, combinations; ophthalmic

16.9

63.6

104

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

6.8

63.4

167

237

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

62.9

2494

17059

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.7

61.9

221

453

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

61.5

2447

16731

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.4

61.3

237

527

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

60.8

1572

9598

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

22.1

59.1

SPAT1153

SPAT

Removal of sutures

1.5

55.7

2483

17331

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

55.6

483

1924

C08CA01

ATC

amlodipine; oral

1.5

55.3

3285

24371

S01BC05

ATC

ketorolac; ophthalmic

2.4

55.0

520

2162

SPAT1262

SPAT

Handing over of treatment supplies

1.6

53.4

1482

9187

ZXA05

NOMESCO Finland

Left side

1.5

52.5

2147

14648

S18

ICPC

Laceration/cut

1.5

52.1

3121

23099

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

257.8

52.0

H35.6

ICD-10 Finland

Retinal haemorrhage

8.6

51.7

116

129

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

51.5

3805

29327

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.8

51.2

180

364

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

51.0

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

46.1

50.7

H35.9

ICD-10 Finland

Retinal disorder, unspecified

12.3

50.2

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

18.4

50.1

H3603, E113

ICD-10 Finland

+∞

50.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

48.9

1560

9997

CS494

NOMESCO Finland

Other visual field testing

5.0

48.8

164

316

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

48.0

1685

11052

M54.5

ICD-10 Finland

Low back pain

1.5

47.7

2015

13788

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

47.3

1755

11654

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

47.0

1378

8633

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

232.9

47.0

M79.6

ICD-10 Finland

Pain in limb

1.5

46.6

2423

17318

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.1

46.0

268

836

R42

ICD-10 Finland

Dizziness and giddiness

1.5

45.5

1943

13304

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

45.2

1745

11678

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

44.1

1267

7879

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

4.3

43.8

171

385

H35.37

ICD-10 Finland

Macular holes

4.6

42.9

154

319

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

42.2

2927

21997

T90

ICPC

Diabetes non-insulin dependent

1.5

42.2

1768

12018

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

41.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

41.6

1259

7925

ZXA00

NOMESCO Finland

Right side

1.4

41.5

2213

15808

SPAT1053

SPAT

Memory test

1.5

41.2

1748

11907

S01BC03

ATC

diclofenac; ophthalmic

3.2

40.9

226

681

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

139.3

40.8

SPAT1260

SPAT

Consultation of another employee

1.6

40.4

1366

8828

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.5

40.3

150

323

UJF32

NOMESCO Finland

Coloscopy

1.5

40.1

2051

14507

N03AX16

ATC

pregabalin; oral

1.5

39.8

1642

11106

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

39.7

2563

18949

L28

ICPC

Limited function/disability (L)

1.5

39.6

1550

10353

XCW10

NOMESCO Finland

Assessment of vision

10.8

39.2

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.6

38.9

140

291

SPAT1254

SPAT

Administration of medicine

1.6

38.9

1341

8699

J01CA04

ATC

amoxicillin; systemic

1.4

38.8

5165

43144

A28

ICPC

Limited function/disability NOS

1.5

38.7

1675

11433

S01ED02

ATC

betaxolol; ophthalmic

7.0

38.7

133

E0000UV

ATC

1.4

38.5

2562

19024

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

38.4

3246

25118

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

38.3

2127

15264

C07AB07

ATC

bisoprolol; oral

1.4

38.1

4242

34342

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

4.8

38.0

132

265

L03

ICPC

Low back symptom/complaint

1.5

38.0

1541

10369

H81

ICPC

Excessive ear wax

1.5

37.4

1427

9462

SPAT1229

SPAT

Assessment of need for aid

1.7

36.9

814

4681

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

36.8

1057

6541

3625A

ICD-9 Finland

Other retinal disorders, Degeneration of macula and posterior pole[DEGENERATIO MACULAE NONEXSUDATIVA]

+∞

36.7

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.4

36.6

186

527

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

36.3

2876

21945

CHC05

NOMESCO Finland

Iridotomy

5.4

36.3

113

201

C10AA01

ATC

simvastatin; oral

1.3

35.4

4086

33085

CKC12

NOMESCO Finland

Photocoagulation of retina

2.9

35.2

229

771

SPAT1216

SPAT

Assessment of functional ability

1.5

34.9

1528

10421

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

17.2

34.9

R53

ICD-10 Finland

Malaise and fatigue

1.5

34.8

1661

11532

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

34.7

2284

16843

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

+∞

34.7

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.8

34.3

225

762

A04

ICPC

Weakness/tiredness general

1.6

34.0

1074

6799

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

33.9

548

2848

H02AB06

ATC

prednisolone; systemic

1.3

33.4

3355

26491

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

33.4

454

2214

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.3

33.1

105

191

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

32.7

1499

10302

H3600, E103

ICD-10 Finland

+∞

32.6

R06.0

ICD-10 Finland

Dyspnoea

1.4

32.5

2011

14636

H40

ICD-10 Finland

Glaucoma

6.4

32.5

132

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

32.4

609

3328

S01EB01

ATC

pilocarpine; ophthalmic

8.7

32.2

SPAT1097

SPAT

Recording of ECG

1.5

31.6

1251

8327

F05

ICPC

Visual disturbance other

2.6

31.4

233

851

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

31.4

478

2430

C03CA01

ATC

furosemide; systemic

1.3

31.3

3236

25569

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

301.0

31.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

31.0

1012

6443

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.6

31.0

237

880

H13

ICPC

Plugged feeling ear

1.5

30.9

1459

10072

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

30.8

760

4504

UDC00

NOMESCO Finland

Ear microscopy

1.8

30.7

524

2772

N06AX11

ATC

mirtazapine; oral

1.4

30.6

2067

15245

A10AE04

ATC

insulin glargine; parenteral

1.7

30.1

621

3492

H91.1

ICD-10 Finland

Presbycusis

1.7

29.9

731

4321

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

29.7

1929

14114

J01MA02

ATC

ciprofloxacin; systemic

1.3

29.5

2932

22964

SPAT1043

SPAT

Audiometry

1.6

29.4

952

6045

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

29.4

2174

16252

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

29.4

2787

21672

P20

ICPC

Memory disturbance

1.4

29.2

1371

9445

L17

ICPC

Foot/toe symptom/complaint

1.4

29.2

1713

12310

K02.1

ICD-10 Finland

Caries of dentine

1.3

28.7

2724

21162

N03AX12

ATC

gabapentin; oral

1.5

28.5

996

6441

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

28.4

2073

15452

CHD35

NOMESCO Finland

Laser goniopuncture

276.8

28.1

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

28.1

1043

6835

1LA05

NOMESCO Finland

6.1

28.0

122

C09CA01

ATC

losartan; oral

1.4

27.9

1897

13964

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

27.7

553

3078

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

27.7

2373

18123

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

27.7

1516

10738

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

27.7

2791

21842

J01AA02

ATC

doxycycline; systemic

1.3

27.6

5387

46247

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

27.4

2413

18496

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

11.0

27.0

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

26.9

2666

20787

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

26.6

1291

8932

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

26.5

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

26.2

705

4273

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.7

26.1

188

676

M48.0

ICD-10 Finland

Spinal stenosis

1.5

25.8

1065

7127

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

25.8

2663

20855

XCH05

NOMESCO Finland

Eye pressure longterm registration

8.0

25.7

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.6

25.5

694

4215

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

25.5

851

5434

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

25.4

1059

7102

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

7.1

25.3

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.7

25.2

124

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

25.1

1756

12949

C10AA05

ATC

atorvastatin; oral

1.3

24.9

3076

24654

A02BC05

ATC

esomeprazole; systemic

1.3

24.6

2648

20822

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

24.5

1904

14268

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

24.5

1837

13690

H3603, E103

ICD-10 Finland

+∞

24.5

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

+∞

24.5

S01EA03

ATC

apraclonidine; ophthalmic

4.6

23.8

174

D07AC01

ATC

betamethasone; topical

1.3

23.8

2201

16919

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

23.8

1823

13623

B01AF02

ATC

apixaban; oral

1.5

23.5

942

6255

CHD99

NOMESCO Finland

Other filtering operation

227.4

23.1

UKC02

NOMESCO Finland

Cystoscopy

1.4

23.0

1391

9989

SPAT1234

SPAT

Support of social functional capacity

1.7

23.0

508

2914

D82

ICPC

Teeth/gum disease

1.4

22.9

1496

10888

R51.80

ICD-10 Finland

Headache

1.5

22.7

722

4550

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

22.5

767

4916

H35.8

ICD-10 Finland

Other specified retinal disorders

7.0

22.5

H3601, E103

ICD-10 Finland

+∞

22.4

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

22.4

674

4196

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.8

22.4

429

2356

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

22.4

1123

7794

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

22.3

5475

47605

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

22.3

1110

7694

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

22.1

1891

14333

H02

ICPC

Hearing complaint

1.4

22.1

1050

7210

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

3.3

22.1

115

335

XKD00

NOMESCO Finland

Uroflowmetry

1.4

22.1

1303

9312

N02AX02

ATC

tramadol; systemic, rectal

1.3

22.0

2927

23574

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

21.9

2031

15574

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

21.9

2138

16519

SPAT1211

SPAT

Application of soft bandage

1.6

21.8

667

4167

D07AC13

ATC

mometasone; topical

1.3

21.8

1762

13245

M01AH05

ATC

etoricoxib; oral

1.3

21.8

3120

25352

H35

ICD-10 Finland

Other retinal disorders

11.9

21.7

R03AC02

ATC

salbutamol; inhalant

1.3

21.7

3149

25623

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

21.6

2396

18825

G04CA02

ATC

tamsulosin; oral

1.3

21.3

1952

14931

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

10.8

21.3

H54.7

ICD-10 Finland

Unspecified visual loss

4.6

21.2

156

L13

ICPC

Hip symptom/complaint

1.4

21.2

1182

8356

H29

ICPC

Ear symptom/complaint other

1.5

21.1

711

4542

H35.36

ICD-10 Finland

Macular cyst

5.4

21.0

113

C09AA05

ATC

ramipril; oral

1.3

20.9

2162

16811

DAX08

NOMESCO Finland

Fitting of hearing aid

1.7

20.9

419

2331

KMAK

NOMESCO Finland

1.3

20.6

2490

19757

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

20.5

1331

9651

N30.0

ICD-10 Finland

Acute cystitis

1.4

20.5

1070

7473

WX199

NOMESCO Finland

Other local analgesia

2.2

20.3

211

921

Z01.2

ICD-10 Finland

Dental examination

1.3

20.2

1909

14649

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

20.1

750

4898

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

20.1

1558

11615

L08

ICPC

Shoulder symptom/complaint

1.4

20.1

1177

8390

T89

ICPC

Diabetes insulin dependent

2.8

20.1

132

452

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

20.0

779

5132

WX002

NOMESCO Finland

Sedation and analgesia

1.4

20.0

1365

9974

J01MA12

ATC

levofloxacin; systemic

1.4

19.7

1366

10002

R01AD09

ATC

mometasone; nasal

1.3

19.7

2196

17222

J01FA10

ATC

azithromycin; systemic

1.3

19.6

2850

23102

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

19.5

1599

12013

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

19.5

1017

7097

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

54.5

19.4

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

19.3

2427

19318

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

4.3

19.3

159

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

19.3

478

2832

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

19.2

1377

10134

G04BD12

ATC

mirabegron; oral

1.4

19.1

842

5687

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

19.1

678

4383

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

19.0

757

5011

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.9

19.0

188

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

18.9

1320

9670

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

18.9

390

2193

H53.0

ICD-10 Finland

Amblyopia ex anopsia

5.1

18.9

112

C08CA13

ATC

lercanidipine; oral

1.4

18.8

1070

7580

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

5.7

18.7

R60.0

ICD-10 Finland

Localized oedema

1.4

18.7

890

6104

C01DA14

ATC

isosorbide mononitrate; oral

1.3

18.4

1813

13961

H3602, E113

ICD-10 Finland

+∞

18.4

H03AA01

ATC

levothyroxine sodium; systemic

1.3

18.2

1555

11738

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

18.1

304

1602

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

5.1

18.0

106

L57.0

ICD-10 Finland

Actinic keratosis

1.4

18.0

947

6614

A10AE05

ATC

insulin detemir; parenteral

1.8

18.0

309

1642

E000001

ATC

1.4

17.9

1211

8820

M01AC06

ATC

meloxicam; systemic, rectal

1.3

17.9

2257

17929

A10BA02

ATC

metformin; oral

1.3

17.9

2101

16547

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

5.1

17.8

104

J01CA08

ATC

pivmecillinam; oral

1.3

17.8

2649

21465

M01AB05

ATC

diclofenac; systemic, rectal

1.2

17.8

3955

33511

1LA01

NOMESCO Finland

23.7

17.6

R05

ICD-10 Finland

Cough

1.3

17.6

1200

8749

L01

ICPC

Neck symptom/complaint

1.5

17.5

741

4965

M03BX02

ATC

tizanidine; oral

1.2

17.4

3103

25637

M15

ICD-10 Finland

Polyarthrosis

1.7

17.3

398

2307

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

17.3

718

4793

F28

ICPC

Limited function/disability (F)

4.1

17.2

155

N06AX21

ATC

duloxetine; oral

1.6

17.1

511

3171

H35.4

ICD-10 Finland

Peripheral retinal degeneration

4.3

17.1

138

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

17.0

849

5871

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

16.9

1179

8623

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

16.9

1144

8329

H43.3

ICD-10 Finland

Other vitreous opacities

3.2

16.9

269

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

16.9

2080

16449

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.7

16.9

114

399

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

16.9

1037

7434

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

16.8

719

4825

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

16.8

482

2960

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

16.8

1734

13411

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

16.8

990

7046

SPAT1172

SPAT

Guidance concerning hydration

1.9

16.8

260

1333

H16.0

ICD-10 Finland

Corneal ulcer

2.0

16.7

210

997

-44

ICPC

Preventive immunization/medic

1.5

16.6

651

4292

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

16.6

493

3054

-1

NOMESCO Finland

1.3

16.6

1473

11162

CKC15

NOMESCO Finland

Panretinal photocoagulation

5.6

16.6

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

16.5

479

2953

R02

ICPC

Shortness of breath/dyspnoea

1.4

16.5

841

5836

H01.0

ICD-10 Finland

Blepharitis

1.9

16.5

254

1300

H44.2

ICD-10 Finland

Degenerative myopia

11.9

16.5

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

16.4

2131

16950

SPAT1101

SPAT

Orthostatic test

1.6

16.3

452

2754

H40.12

ICD-10 Finland

Pigmentary glaucoma

+∞

16.3

S01.0

ICD-10 Finland

Open wound of scalp

1.5

16.3

527

3336

S06.0

ICD-10 Finland

Concussion

1.5

16.2

632

4162

H02.3

ICD-10 Finland

Blepharochalasis

1.6

16.2

460

2820

A10BH05

ATC

linagliptin; oral

1.6

16.2

408

2426

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.6

16.2

408

2428

M01AX05

ATC

glucosamine; oral

1.3

16.1

1762

13717

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

16.1

257

1333

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

16.1

522

3303

H54.5

ICD-10 Finland

Severe visual impairment, monocular

5.5

16.0

R01AD12

ATC

fluticasone furoate; nasal

1.3

15.9

1123

8219

N05BA04

ATC

oxazepam; oral

1.3

15.9

1624

12525

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

15.9

565

3650

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

15.9

557

3586

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

15.7

965

6907

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

15.7

525

3341

P01AB01

ATC

metronidazole; oral, rectal

1.2

15.7

2215

17767

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

15.6

907

6433

VALMI

NOMESCO Finland

1.3

15.6

1064

7748

R05

ICPC

Cough

1.3

15.6

1266

9461

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

15.5

438

2684

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

15.5

476

2977

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

15.4

620

4108

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

15.4

183

849

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.1

15.3

180

832

A01

ICPC

Pain general/multiple sites

1.5

15.2

527

3386

M25.5

ICD-10 Finland

Pain in joint

1.3

15.2

1412

10753

J01FF01

ATC

clindamycin; systemic

1.3

15.1

1548

11934

H40.8

ICD-10 Finland

Other glaucoma

24.9

15.1

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

15.0

867

6139

F29

ICPC

Eye symptom/complaint other

1.6

15.0

450

2794

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

15.0

604

4003

H57.1

ICD-10 Finland

Ocular pain

2.2

14.9

146

623

B01AC04

ATC

clopidogrel; oral

1.3

14.9

1383

10523

SPAT1167

SPAT

Insertion of urinary catheter

1.7

14.9

313

1770

N05CF01

ATC

zopiclone; oral

1.2

14.9

2515

20558

R06AE07

ATC

cetirizine; oral

1.2

14.8

2319

18798

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

14.8

390

2345

R3120

NOMESCO Finland

Training in mobility skills

16.8

14.6

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

14.6

706

4851

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

14.6

204

1009

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

14.5

703

4833

A10BH01

ATC

sitagliptin; oral

1.4

14.4

662

4500

M02AA07

ATC

piroxicam; topical

1.2

14.4

2680

22114

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

14.3

669

4564

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

14.3

337

1972

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

14.3

N04BC05

ATC

pramipexole; oral

1.5

14.1

534

3497

G47.3

ICD-10 Finland

Sleep apnoea

1.3

14.1

969

7059

S01EA02

ATC

dipivefrine; ophthalmic

9.2

14.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

14.0

1129

8416

WX142

NOMESCO Finland

Sub-tenon anesthesy

5.5

14.0

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

14.0

813

5766

SPAT1058

SPAT

PEF monitoring instruction

1.5

13.9

508

3300

C09CA06

ATC

candesartan; oral

1.3

13.9

1320

10064

WX320

NOMESCO Finland

Spinalanesthesy

1.3

13.9

1513

11741

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.0

13.8

248

207

Kela drug reimbursment

Chronic arrhythmias

1.3

13.7

1408

10844

B01AB05

ATC

enoxaparin; parenteral

1.2

13.7

2153

17427

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

13.7

958

6996

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

13.7

225

1181

G44.2

ICD-10 Finland

Tension-type headache

1.4

13.6

625

4252

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

13.5

262

1449

ZXC50

NOMESCO Finland

Cryotherapy

1.7

13.5

274

1537

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

13.5

712

4965

H40.1

ICD-10 Finland

Primary open-angle glaucoma

14.9

13.4

RS222

NOMESCO Finland

2.5

13.4

102

383

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

13.3

543

3609

L14

ICPC

Leg/thigh symptom/complaint

1.5

13.3

494

3219

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

13.3

907

6599

WZA90

NOMESCO Finland

Other doctors statement

1.3

13.3

1124

8437

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

13.2

2982

25015

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

13.2

171

824

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

13.2

3780

32423

A02BC03

ATC

lansoprazole; oral

1.2

13.2

2061

16659

J01FA06

ATC

roxithromycin; oral

1.2

13.2

2514

20743

J02AC01

ATC

fluconazole; systemic

1.2

13.2

1895

15183

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

13.1

1855

14831

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

13.1

697

4869

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

3.2

13.1

202

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

13.9

13.1

K85

ICPC

Elevated blood pressure

1.3

13.1

1157

8734

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

13.1

504

3311

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

13.1

784

5588

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

6.3

13.0

A06AD11

ATC

lactulose; oral

1.3

12.9

1346

10377

G04CA01

ATC

alfuzosin; oral

1.4

12.9

803

5755

H20.1

ICD-10 Finland

Chronic iridocyclitis

3.7

12.9

140

U02

ICPC

Urinary frequency/urgency

1.3

12.9

859

6226

M05BA04

ATC

alendronic acid; oral

1.3

12.8

828

5970

N17

ICPC

Vertigo/dizziness

1.3

12.8

829

5975

K59.0

ICD-10 Finland

Constipation

1.5

12.8

439

2813

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

12.8

1184

8991

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

12.8

527

3511

D06BX01

ATC

metronidazole; topical

1.4

12.7

546

3667

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.7

1185

9010

SPAT1360

SPAT

Extensive global examination

1.4

12.7

552

3716

SPAT1009

SPAT

Measurement of intraocular pressure

2.6

12.7

332

D01BA02

ATC

terbinafine; oral; topical

1.3

12.7

1466

11450

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

12.7

299

1751

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

12.6

785

5627

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

12.6

1076

8080

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

12.6

419

2669

RS226

NOMESCO Finland

26.8

12.6

R4135

NOMESCO Finland

Rehabilitation for hearing problems

1.9

12.6

178

887

A29

ICPC

General symptom/complaint other

1.4

12.5

780

5596

JN4AD

NOMESCO Finland

Body CT examination

1.5

12.4

503

3340

S97

ICPC

Chronic ulcer skin

1.5

12.3

408

2594

J01EA01

ATC

trimethoprim; systemic

1.2

12.3

1892

15246

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.4

12.3

585

4003

H25.9

ICD-10 Finland

Senile cataract, unspecified

2.0

12.3

153

728

3708

FHL

Trabeculectomy or equivalent

+∞

12.2

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

12.2

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.6

12.2

142

A46

ICD-10 Finland

Erysipelas

1.3

12.2

1006

7518

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

12.1

1099

8316

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

12.1

1567

12389

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.8

12.1

251

SPAT1125

SPAT

Stoma care and guidance

2.0

12.1

157

758

L29

ICPC

Musculoskeletal sympt/complt other

1.5

12.0

457

2995

H84

ICPC

Presbyacusis

1.6

12.0

337

2064

CKD60

NOMESCO Finland

Anterior vitrectomy

2.6

12.0

319

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

12.0

531

3587

H54.1

ICD-10 Finland

Severe visual impairment, binocular

7.4

12.0

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

12.0

1042

7843

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.5

12.0

364

2272

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

12.0

675

4760

WX290

NOMESCO Finland

Other blockade of nerve

1.2

12.0

1522

12005

F93

ICPC

Glaucoma

7.8

12.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

12.0

480

3182

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

8.2

11.9

CKC20

NOMESCO Finland

Cryopexy of undetached retina

8.8

11.9

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.1

11.9

103

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

11.9

770

5551

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

11.9

1528

12065

L15

ICPC

Knee symptom/complaint

1.3

11.9

1266

9780

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

11.8

433

2816

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

11.8

184

950

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

11.8

671

4736

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

11.7

281

1653

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

11.7

378

2393

H61.2

ICD-10 Finland

Impacted cerumen

1.5

11.6

387

2467

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

11.6

2136

17509

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.8

11.6

194

1027

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.6

11.6

RK321

NOMESCO Finland

12.6

11.5

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.8

11.5

198

1058

H04AA01

ATC

glucagon; nasal, parenteral

3.4

11.5

150

M54

ICD-10 Finland

Dorsalgia

1.4

11.5

545

3731

C03AA03

ATC

hydrochlorothiazide; oral

1.3

11.5

819

5995

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

11.4

516

3497

N05AH04

ATC

quetiapine; oral

1.3

11.4

740

5337

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.8

11.4

190

1005

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

11.3

405

2618

SPAT1251

SPAT

Organisation of medication

1.6

11.3

313

1910

H44.0

ICD-10 Finland

Purulent endophthalmitis

7.9

11.3

S22.3

ICD-10 Finland

Fracture of rib

1.5

11.2

398

2570

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

11.2

305

1855

S70.0

ICD-10 Finland

Contusion of hip

1.6

11.2

287

1720

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

11.1

841

6206

J05AB11

ATC

valaciclovir; oral

1.3

11.1

693

4967

G04CB02

ATC

dutasteride; oral

1.4

11.1

495

3346

1LA04

NOMESCO Finland

10.5

11.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

11.0

531

3641

R74

ICPC

Upper respiratory infection acute

1.3

11.0

916

6847

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

11.0

1103

8450

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

10.9

879

6546

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

10.9

287

1733

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

10.9

250

1457

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

10.8

319

1977

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

10.8

419

2758

RK322

NOMESCO Finland

9.9

10.8

L16

ICPC

Ankle symptom/complaint

1.4

10.8

521

3577

CFW99

NOMESCO Finland

Other operation on conjunctiva

23.7

10.8

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.6

10.8

123

J20

ICD-10 Finland

Acute bronchitis

1.4

10.8

522

3582

CKD15

NOMESCO Finland

Injection of vitreous substitute

4.7

10.7

S82

ICPC

Naevus/mole

1.4

10.7

646

4608

N07CA01

ATC

betahistine; oral

1.4

10.7

551

3830

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

10.6

1495

11909

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

10.6

602

4248

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

10.6

122

563

R55

ICD-10 Finland

Syncope and collapse

1.3

10.6

867

6471

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

10.5

243

1416

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

10.5

412

2716

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

10.5

259

1538

A02BC01

ATC

omeprazole; systemic

1.2

10.5

2024

16644

H53.4

ICD-10 Finland

Visual field defects

2.0

10.5

136

658

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

10.4

157

804

R11

ICD-10 Finland

Nausea and vomiting

1.4

10.4

522

3610

EBA00

NOMESCO Finland

Extraction of tooth

1.2

10.4

1650

13307

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

56.8

10.4

H53.2

ICD-10 Finland

Diplopia

1.8

10.3

184

993

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

1.7

10.3

204

1140

S01

ICPC

Pain/tenderness of skin

1.6

10.3

254

1508

M01AH02

ATC

rofecoxib; oral

1.3

10.3

960

7284

C08CA02

ATC

felodipine; oral

1.3

10.3

809

6000

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

10.3

1761

14310

H53

ICD-10 Finland

Visual disturbances

3.7

10.3

114

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

1.9

10.2

155

795

HAHOM

NOMESCO Finland

2.9

10.2

196

C02AC05

ATC

moxonidine; oral

1.5

10.2

316

1983

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

10.2

500

3444

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

104.1

10.2

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

104.1

10.2

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

10.1

268

1621

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

10.1

368

2392

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

10.1

577

4078

M01AE02

ATC

naproxen; oral, rectal

1.2

10.1

3101

26537

R01AD01

ATC

beclometasone; nasal

1.3

10.0

751

5530

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

10.0

804

5981

A10AA01

ATC

2.6

10.0

267

C10AA07

ATC

rosuvastatin; oral

1.2

9.9

1525

12249

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

9.9

370

2421

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

9.9

1051

8104

R33

ICD-10 Finland

Retention of urine

1.3

9.9

641

4620

XJH00

NOMESCO Finland

Transanal ultrasonography

1.4

9.9

505

3505

R13

ICD-10 Finland

Dysphagia

1.4

9.8

428

2884

H35.3

ICD-10 Finland

Degeneration of macula and posterior pole

8.3

9.8

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.7

9.8

209

1195

N06AB10

ATC

escitalopram; oral

1.3

9.8

769

5700

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

9.7

330

2112

H02.4

ICD-10 Finland

Ptosis of eyelid

1.8

9.7

173

934

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

9.7

1415

11301

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

9.7

1555

12546

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

9.7

338

2181

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.4

9.6

541

3812

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.7

9.6

192

1078

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

9.6

634

4586

SPAT1285

SPAT

Provision of consultation response

1.5

9.6

346

2246

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

9.6

1314

10426

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

9.6

121

582

A03

ICPC

Fever

1.4

9.6

562

3991

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

9.5

253

1531

I95.1

ICD-10 Finland

Orthostatic hypotension

1.5

9.5

314

2003

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

9.5

646

4694

A10AA02

ATC

1.8

9.5

152

795

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.8

9.5

169

917

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

9.4

603

4338

CKA10

NOMESCO Finland

Biopsy of vitreous body

7.2

9.4

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

9.4

585

4191

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.8

9.4

146

754

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

9.4

417

2819

R4180

NOMESCO Finland

Podiatric therapy

2.7

9.4

213

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

10.0

9.4

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

9.4

161

863

M05BX04

ATC

denosumab; parenteral

1.4

9.4

397

2663

E000006

ATC

1.4

9.4

423

2870

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

9.4

1148

8998

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.7

9.3

191

1080

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

9.3

399

2678

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

9.3

243

1468

N18.8

ICD-10 Finland

Other chronic renal failure

1.7

9.3

204

1178

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

9.3

1090

8504

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.6

9.3

212

1236

S29

ICPC

Skin symptom/complaint other

1.3

9.2

1027

7957

K78

ICPC

Atrial fibrillation/flutter

1.3

9.2

718

5316

XF404

NOMESCO Finland

Ambulatory ECG

1.3

9.2

636

4631

F84

ICPC

Macular degeneration

94.6

9.2

R95

ICPC

Chron obstructive pulmonary disease

1.7

9.2

189

1069

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

9.1

217

1277

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.8

9.1

145

757

D07AD01

ATC

clobetasol; topical

1.3

9.1

836

6332

205

Kela drug reimbursment

Chronic hypertension

1.2

9.1

2609

22149

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.1

793

5963

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

9.0

353

2328

J01MA06

ATC

norfloxacin; oral

1.3

9.0

914

7005

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

9.0

1028

7989

H35.1

ICD-10 Finland

Retinopathy of prematurity

11.6

9.0

R06AX27

ATC

desloratadine; oral

1.3

9.0

983

7601

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.5

9.0

293

1865

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.5

9.0

325

2116

R03BB04

ATC

tiotropium bromide; inhalant

1.3

8.9

771

5787

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.3

8.9

313

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

8.9

353

2337

SPAT1059

SPAT

Spirometry at the office

1.5

8.9

307

1976

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

5.8

8.9

J01FA09

ATC

clarithromycin; systemic

1.2

8.9

1475

11926

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.2

8.9

383

R01AD08

ATC

fluticasone; nasal

1.2

8.9

1310

10468

Z00.0

ICD-10 Finland

General medical examination

1.2

8.8

1091

8554

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.8

4006

35183

M54.2

ICD-10 Finland

Cervicalgia

1.5

8.8

313

2026

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

8.8

410

2798

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.6

8.8

209

1232

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

8.7

338

2229

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

8.7

332

2181

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

8.7

122

611

C07AG02

ATC

carvedilol; oral

1.4

8.7

472

3310

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

2.0

8.7

105

498

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

1.8

8.6

145

773

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

8.6

574

4158

J05AB01

ATC

aciclovir; systemic

1.2

8.6

1145

9051

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.6

1402

11314

L86

ICPC

Back syndrome with radiating pain

1.5

8.6

297

1914

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

8.6

163

904

AN1

Coronary angiography

1.2

8.6

1020

7964

C09CA03

ATC

valsartan; oral

1.3

8.6

595

4337

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.1

8.5

402

S01AX11

ATC

[U] ofloxacin; ophthalmic

1.5

8.5

271

1712

H52.0

ICD-10 Finland

Hypermetropia

2.3

8.5

329

R52.2

ICD-10 Finland

Other chronic pain

1.7

8.5

169

948

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

8.5

336

2223

N02AA05

ATC

oxycodone; systemic

1.2

8.5

1167

9256

XG410

NOMESCO Finland

Flow-volume spirometry

1.5

8.5

242

1494

H26.2

ICD-10 Finland

Complicated cataract

2.6

8.5

222

K86

ICPC

Hypertension uncomplicated

1.3

8.5

871

6684

C09DA01

ATC

losartan and diuretics; oral

1.3

8.5

697

5202

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

8.5

813

6189

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.3

8.5

578

4203

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

8.5

1374

11083

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

8.4

122

617

U01

ICPC

Dysuria/painful urination

1.4

8.4

414

2853

R81

ICPC

Pneumonia

1.6

8.4

200

1178

B02.9

ICD-10 Finland

Zoster without complication

1.4

8.4

374

2534

H52.1

ICD-10 Finland

Myopia

2.3

8.4

295

H44.5

ICD-10 Finland

Degenerated conditions of globe

13.2

8.4

R44.1

ICD-10 Finland

Visual hallucinations

2.9

8.4

161

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

8.4

669

4974

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.5

8.3

288

1857

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.5

8.3

247

N06AX16

ATC

venlafaxine; oral

1.4

8.3

454

3189

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

8.2

637

4711

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.5

8.2

236

1458

C07AB02

ATC

metoprolol; systemic

1.2

8.2

1903

15844

CHD10

NOMESCO Finland

Trabeculectomy

+∞

8.2

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

8.2

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

+∞

8.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

8.1

287

1860

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

8.1

404

2794

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

8.1

1503

12274

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

8.1

1155

9198

K07

ICPC

Swollen ankles/oedema

1.4

8.0

351

2371

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.8

8.0

134

713

G03CA04

ATC

estriol; systemic, vaginal

1.3

8.0

734

5555

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

8.0

586

4308

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

8.0

269

1727

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

8.0

582

4272

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

8.0

254

1611

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

7.9

1322

10682

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

7.9

1324

10699

I49.5

ICD-10 Finland

Sick sinus syndrome

1.4

7.9

366

2498

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

13.7

7.9

I50.0

ICD-10 Finland

Congestive heart failure

1.3

7.9

748

5685

M02AA10

ATC

ketoprofen; topical

1.2

7.8

996

7831

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

7.8

351

2380

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.4

7.8

412

2875

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

7.8

322

2152

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.6

7.8

187

1110

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

7.8

881

6842

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

7.8

305

2018

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.3

7.7

493

3548

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

7.7

808

6214

SPAT1014

SPAT

Treatment of eyes

1.8

7.7

133

716

L12

ICPC

Hand/finger symptom/complaint

1.3

7.7

693

5237

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

3.6

7.6

U05

ICPC

Urination problems other

1.4

7.6

322

2160

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.2

7.6

1038

8223

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.6

7.6

204

1244

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

7.6

311

2077

SPF30

NOMESCO Finland

Soling for prothesis

1.7

7.5

156

887

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.7

7.5

139

767

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

42.5

7.5

SPAT1104

SPAT

Monitoring of emergency patient

1.4

7.5

428

3026

X58

ICD-10 Finland

Exposure to other specified factors

1.3

7.5

564

4159

U07

ICPC

Urine symptom/complaint other

1.4

7.5

381

2647

M79.1

ICD-10 Finland

Myalgia

1.3

7.5

592

4399

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.8

7.5

124

663

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.8

7.5

127

681

WZC00

SPAT

1.6

7.4

182

1085

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.7

7.4

159

915

F99

ICPC

Eye/adnexa disease other

2.8

7.4

147

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.8

7.4

118

621

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

7.4

348

2382

A08

ICPC

Swelling

1.4

7.4

294

1952

B03BA03

ATC

hydroxocobalamin; parenteral

1.3

7.4

473

3409

N05AD03

ATC

melperone; systemic

0.4

7.4

684

RK320

NOMESCO Finland

2.3

7.4

263

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.4

7.4

358

2467

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.6

7.4

184

1100

F83

ICPC

Retinopathy

23.6

7.3

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.3

7.3

503

3658

OAB42

SPAT

1.6

7.3

198

1208

N06AA09

ATC

amitriptyline; systemic

1.3

7.3

608

4546

SPAT1252

SPAT

Overall medication plan or its review

1.3

7.3

528

3873

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.3

2483

21265

WW200

SPAT

1.4

7.3

392

2747

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

7.3

521

3814

N03AE01

ATC

clonazepam; systemic

1.4

7.3

303

2030

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

7.3

683

5186

D07AB08

ATC

desonide; topical

1.3

7.3

571

4236

R52.9

ICD-10 Finland

Pain, unspecified

1.3

7.2

450

3226

R04.0

ICD-10 Finland

Epistaxis

1.3

7.2

538

3960

CK2Z4

NOMESCO Finland

Ocular fundus light imaging (OCT), angiography

75.7

7.2

H53.8

ICD-10 Finland

Other visual disturbances

2.4

7.2

241

N30

ICD-10 Finland

Cystitis

1.4

7.2

409

2890

SPAT1255

SPAT

Intravenous administration of medicine

1.4

7.2

401

2827

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

7.2

422

2999

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.2

1535

12675

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

7.2

1416

11611

S01AD03

ATC

aciclovir; ophthalmic

1.6

7.2

198

1216

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.3

7.2

569

4229

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.1

1143

9197

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

7.1

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

+∞

7.1

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

7.1

F01

ICPC

Eye pain

1.8

7.1

117

622

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.1

7.1

109

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

7.1

281

1864

130

Kela drug reimbursment

Malignant tumour

0.7

7.1

352

4396

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

7.1

464

3354

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.7

7.1

150

860

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.5

7.1

265

1739

J01MA14

ATC

moxifloxacin; systemic

1.3

7.1

497

3633

L60.0

ICD-10 Finland

Ingrowing nail

1.5

7.1

215

1352

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

7.0

189

1155

C10AA04

ATC

fluvastatin; oral

1.2

7.0

759

5858

B01AF01

ATC

rivaroxaban; oral

1.2

7.0

836

6524

SFA00

NOMESCO Finland

Small filling

1.3

7.0

535

3954

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

7.0

367

2562

G04BD08

ATC

solifenacin; oral

1.3

7.0

508

3731

N01

ICPC

Headache

1.4

7.0

340

2346

E000002

ATC

1.3

7.0

508

3733

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

1.8

7.0

106

550

D02

ICPC

Abdominal pain epigastric

1.4

7.0

268

1771

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.8

7.0

104

536

R03BA05

ATC

fluticasone; inhalant

1.2

7.0

942

7455

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

7.0

384

2706

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.5

7.0

259

1697

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.3

6.9

471

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

2.0

6.9

381

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.7

6.9

137

773

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

6.9

334

2301

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

6.9

478

3484

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.3

6.9

424

3037

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

6.9

190

1168

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

6.9

285

1908

SBB10

NOMESCO Finland

Teeth copy

1.6

6.9

182

1108

B01AA03

ATC

warfarin; systemic

1.2

6.9

2004

16957

K29

ICPC

Cardiovascular sympt/complt other

1.4

6.8

290

1953

R05FB02

ATC

cough suppressants and expectorants

1.1

6.8

2572

22164

H52.2

ICD-10 Finland

Astigmatism

2.3

6.8

227

E000003

ATC

1.5

6.8

215

1362

A02BC04

ATC

rabeprazole; oral

1.4

6.8

379

2672

M54.3

ICD-10 Finland

Sciatica

1.4

6.8

298

2016

S16

ICPC

Bruise/contusion

1.5

6.8

207

1301

H54.4

ICD-10 Finland

Blindness, monocular

4.4

6.8

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

1.8

6.8

108

569

A11

ICPC

Chest pain NOS

1.3

6.8

479

3502

F38

ICPC

Eye, Other laboratory test NEC

3.6

6.8

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

6.7

658

5019

H27.1

ICD-10 Finland

Dislocation of lens

3.0

6.7

114

SPAT1138

SPAT

Guidance concerning bowel function

1.8

6.7

112

601

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

6.7

143

823

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

6.7

617

4673

78930

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Haematuria

2.4

6.7

205

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

6.7

143

825

K12.12

ICD-10 Finland

Stomatitis ulcerative

2.3

6.7

235

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

1.8

6.7

107

564

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

3.2

6.7

XKC03

NOMESCO Finland

Water cystometry

1.5

6.7

192

1193

S21

ICPC

Skin texture symptom/complaint

1.2

6.6

728

5630

R06AE09

ATC

levocetirizine; oral

1.3

6.6

531

3952

A10BB12

ATC

glimepiride; oral

1.3

6.6

595

4490

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.6

662

5066

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

6.6

1065

8572

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.5

6.6

217

1387

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.3

6.6

385

2736

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

6.6

691

5316

G45.3

ICD-10 Finland

Amaurosis fugax

1.7

6.6

132

749

H28

ICPC

Limited function/disability (H)

2.0

6.6

369

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

2.1

6.6

312

XF640

NOMESCO Finland

1.5

6.5

212

1353

Z46.2

ICD-10 Finland

Fitting and adjustment of other devices related to nervous system and special senses

10.3

6.5

H54.0

ICD-10 Finland

Blindness, binocular

7.8

6.5

R50.9

ICD-10 Finland

Fever, unspecified

1.2

6.5

785

6135

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

6.5

294

2000

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.5

265

1771

M75

ICD-10 Finland

Shoulder lesions

1.5

6.5

207

1315

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.5

6.5

204

1292

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

6.5

309

2125

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.1

6.5

327

WZC30

NOMESCO Finland

Teaching

1.3

6.5

669

5142

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.4

442

3221

L76

ICPC

Fracture: other

1.5

6.4

191

1194

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

2.0

6.4

354

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

6.4

221

1430

R31

ICD-10 Finland

Unspecified haematuria

1.2

6.4

731

5678

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

6.4

135

777

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

1.6

6.4

156

934

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.6

6.4

146

857

K90

ICPC

Stroke/cerebrovascular accident

1.5

6.4

205

1306

H92.0

ICD-10 Finland

Otalgia

1.5

6.4

199

1259

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

6.3

571

4312

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

11.6

6.3

R12

ICD-10 Finland

Heartburn

1.4

6.3

332

2318

C09DA03

ATC

valsartan and diuretics; oral

1.4

6.3

293

2006

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.7

6.3

131

750

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

6.3

321

2233

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

6.3

221

1436

K05

ICPC

Irregular heartbeat other

1.5

6.3

200

1270

C09AA02

ATC

enalapril; systemic

1.2

6.3

1621

13575

I77.6

ICD-10 Finland

Arteritis, unspecified

3.3

6.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

6.3

171

1050

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

2.5

6.3

177

A06AC51

ATC

ispaghula, combinations; systemic

1.4

6.2

286

1954

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.6

6.2

151

900

S94

ICPC

Ingrowing nail

1.9

6.2

421

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

6.2

103

552

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.5

6.2

203

1301

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

6.2

348

2461

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

6.2

418

3043

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.2

171

1053

G03DC05

ATC

[U] tibolone; oral

1.4

6.2

308

2138

K30

ICD-10 Finland

Functional dyspepsia

1.3

6.2

517

3872

XQ848

NOMESCO Finland

Dermatological photography

1.6

6.2

149

889

D11

ICPC

Diarrhoea

1.3

6.2

424

3090

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

6.1

872

6929

E03

ICD-10 Finland

Other hypothyroidism

1.4

6.1

309

2144

S04

ICPC

Lump/swelling localized

1.3

6.1

448

3291

S01.50

ICD-10 Finland

Open wound in oral cavity

2.3

6.1

219

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

0.0

6.1

148

D01AE16

ATC

amorolfine; topical

1.2

6.1

723

5638

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.5

6.1

217

1411

SPAT1050

SPAT

Extensive neurological examination

1.6

6.1

147

874

S01EB02

ATC

carbachol; ophthalmic

+∞

6.1

H3601, E119

ICD-10 Finland

+∞

6.1

A01AB09

ATC

miconazole; local oral

1.3

6.1

598

4566

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.1

399

2889

WX723

NOMESCO Finland

CPAP therapy

1.7

6.1

113

626

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

6.1

323

2263

K40

ICD-10 Finland

Inguinal hernia

1.7

6.1

127

729

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

6.1

170

1050

H33.3

ICD-10 Finland

Retinal breaks without detachment

1.6

6.1

156

945

L04AA06

ATC

mycophenolic acid; systemic

2.2

6.1

241

W19

ICD-10 Finland

Unspecified fall

1.3

6.1

591

4509

U04

ICPC

Incontinence urine

1.3

6.1

345

2447

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

6.0

553

4188

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.5

6.0

176

1100

S76

ICPC

Skin infection other

1.4

6.0

268

1823

H81.4

ICD-10 Finland

Vertigo of central origin

2.2

6.0

242

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.4

6.0

322

2259

R03BA08

ATC

ciclesonide; inhalant

1.3

6.0

356

2538

R03DC03

ATC

montelukast; oral

1.2

6.0

693

5391

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019550) Sodium [Moles/volume] in Serum or Plasma

7909

63600

2.73

182.18

26.4

22.5

139.3

139.5

mmol/l

8.10

7659

61694

(3023103) Potassium [Moles/volume] in Serum or Plasma

7914

63667

2.74

181.99

26.6

22.7

4.0

mmol/l

6.33

7652

61656

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7621

60350

2.45

179.30

21.9

18.6

26.1

27.9

mg/l

4.60

6601

50257

(3010813) Leukocytes [#/volume] in Blood

7944

64205

2.74

177.40

32.4

27.4

7.1

7.0

e9/l

1.40

7659

61569

(3000963) Hemoglobin [Mass/volume] in Blood

7943

64199

2.74

177.24

32.6

27.6

128.3

130.2

g/l

22.82

7761

62684

(3035941) MCH [Entitic mass]

7942

64187

2.74

177.24

32.2

27.3

30.4

0.17

7755

62659

(3024731) MCV [Entitic volume]

7942

64189

2.74

177.19

32.3

27.3

92.0

91.9

1.53

7755

62665

(3026361) Erythrocytes [#/volume] in Blood

7942

64190

2.74

177.16

32.4

27.4

4.3

e12/l

21.71

7663

61541

(3007461) Platelets [#/volume] in Blood

7940

64183

2.73

176.72

32.4

27.4

238.5

239.9

e9/l

1.07

7682

61834

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7770

62533

2.49

167.53

25.6

22.2

89.0

84.2

umol/l

16.67

7765

62500

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7751

62401

2.46

165.30

12.6

11.4

22.9

23.3

u/l

0.45

7300

59196

(40761511) CBC panel - Blood by Automated count

7562

60506

2.29

158.73

22.5

18.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6193

46469

1.88

150.96

6.3

5.6

3250.8

1785.2

e6/l

0.78

845

(3037467) Urinalysis macro (dipstick) panel - Urine

6162

46165

1.88

150.91

5.7

5.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7323

58183

2.13

150.81

5.6

5.3

6.2

6.1

mmol/l

5.43

6185

50962

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7029

55039

2.03

150.33

5.5

5.0

2.1

mu/l

0.25

6055

48652

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7124

56082

2.06

149.60

7.4

6.7

41.8

41.0

mmol/mol

9.78

6205

50087

(3013707) Erythrocyte sedimentation rate by Westergren method

6201

46620

1.87

149.25

4.9

4.3

16.4

15.7

mm/h

2.54

5481

42108

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4352

29492

1.78

147.72

5.3

4.4

74.7

87.2

ng/l

0.21

3602

23300

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6601

50735

1.92

146.95

7.9

7.4

82.7

82.1

u/l

0.32

6103

47067

(3013826) Glucose [Moles/volume] in Serum or Plasma

5621

41119

1.81

146.43

5.0

4.6

7.0

6.9

mmol/l

4.48

5334

38555

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7234

58088

2.00

130.83

5.6

5.5

2.4

2.5

mmol/l

14.77

6237

51365

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5207

38093

1.72

126.20

6.9

6.3

1.2

mmol/l

2.11

4108

31739

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5955

45379

1.75

122.72

4.4

4.1

15.4

15.2

pmol/l

5.60

5053

39849

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6936

55341

1.87

121.61

5.0

4.7

1.5

mmol/l

0.49

5932

48662

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7005

56068

1.89

121.59

5.0

4.8

4.3

4.4

mmol/l

9.27

6053

49743

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2683

16563

1.77

118.65

1.8

1.7

15745353.3

24469987.9

pmol/l

0.48

2007

13102

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4904

35976

1.65

110.98

5.4

5.7

11.9

12.4

umol/l

1.70

4590

33860

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3886

26881

1.66

110.80

3.5

3.2

2124.8

1979.5

ng/l

0.93

3323

23400

(3032080) INR in Blood by Coagulation assay

4464

32029

1.65

109.84

12.3

11.5

1.3

1.4

inr

1.48

1397

8220

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6705

53525

1.78

109.49

4.5

4.2

1.2

mmol/l

1.19

5658

46463

(3009261) Glucose [Presence] in Urine by Test strip

4483

32358

1.63

106.34

5.1

4.4

0.0

estimate

1.08

949

5621

(3035350) Ketones [Presence] in Urine by Test strip

4431

31907

1.63

105.98

5.0

4.4

0.0

estimate

0.00

948

5684

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3206

21300

1.67

105.44

2.6

2.5

58.1

60.1

u/l

1.00

2906

19370

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3523

23989

1.65

105.17

5.5

4.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6854

55312

1.78

104.55

20.6

18.1

65.9

68.6

ml/min/173m2

22.51

5843

45693

(3021601) Nitrite [Presence] in Urine by Test strip

4425

31945

1.62

103.97

6.6

5.9

0.0

estimate

0.50

957

5640

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3061

20298

1.65

100.11

2.6

2.3

3.3

3.2

mg/l

1.97

2530

17022

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4683

34579

1.60

97.74

6.1

5.6

1.2

mmol/l

2.35

4059

30753

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3649

25419

1.61

96.96

3.3

2.9

144.8

155.1

ug/l

1.25

3152

22614

(3013512) EKG study

3205

21748

1.62

94.08

5.1

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4504

33300

1.57

90.63

3.4

3.1

61.1

56.1

u/l

1.60

3918

29599

(3019309) Folate [Moles/volume] in Red Blood Cells

2758

18184

1.63

90.05

2.0

1.8

1228.2

1158.1

nmol/l

3.02

1972

13310

(3024561) Albumin [Mass/volume] in Serum or Plasma

4413

32525

1.57

89.63

4.6

4.4

33.8

34.2

g/l

5.60

3951

29579

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4384

32529

1.55

84.39

2.3

2.2

93.8

92.9

pmol/l

0.47

2193

16479

(3026008) Bacteria identified in Urine by Culture

3712

26567

1.56

83.90

4.1

3.7

—

(3029937) Albumin [Presence] in Urine by Test strip

2654

17575

1.61

83.83

5.5

4.8

0.0

estimate

0.11

907

5388

(3009542) Hematocrit [Volume Fraction] of Blood

6256

50454

1.60

81.64

22.1

20.7

36.0

37.5

11.02

3034

29080

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3259

22751

1.56

81.63

2.3

2.1

187.0

224.3

u/l

1.73

2998

21044

(3013650) Neutrophils [#/volume] in Blood by Automated count

4783

36333

1.54

81.52

8.1

8.2

4.6

4.4

e9/l

5.07

4186

31052

(3041096) Erythrocytes [Presence] in Urine by Automated

2423

15827

1.62

80.28

4.9

4.3

—

(3023368) Bacteria identified in Blood by Culture

3235

22618

1.56

80.06

4.3

4.2

—

(3006315) Basophils [#/volume] in Blood

4185

31053

1.52

78.26

5.5

5.3

0.0

e9/l

1.39

3587

25993

(3013115) Eosinophils [#/volume] in Blood

4284

31957

1.52

78.06

5.6

5.5

0.2

e9/l

0.24

3681

27140

(3001604) Monocytes [#/volume] in Blood

4150

30835

1.52

76.44

5.5

5.3

0.6

e9/l

0.47

3556

25775

(3019198) Lymphocytes [#/volume] in Blood

4222

31548

1.51

75.25

5.7

5.4

1.8

1.9

e9/l

1.18

3662

26833

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2132

13735

1.62

73.65

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2840

19592

1.55

72.91

1.7

1.6

20.6

20.3

nmol/l

0.42

2279

16470

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3745

27434

1.51

72.46

2.4

2.2

82.2

80.8

nmol/l

2.14

3134

23457

(40760892) CBC W Ordered Manual Differential panel - Blood

1827

11394

1.65

71.60

4.7

4.5

—

(42870588) Differential panel, method unspecified - Blood

3136

22266

1.52

69.66

5.5

5.4

—

(40761536) Microorganisms panel - Urine sediment

1000

5328

1.88

67.71

5.3

4.7

—

(3019069) Monocytes/100 leukocytes in Blood

3934

29388

1.48

67.47

6.3

6.0

9.0

8.9

0.05

3590

26905

(3002030) Lymphocytes/100 leukocytes in Blood

3980

29825

1.48

67.03

6.2

5.9

24.1

25.3

9.58

3589

27089

(3015377) Calcium [Moles/volume] in Serum or Plasma

3487

25463

1.49

66.78

3.0

3.2

2.3

2.4

mmol/l

4.66

2876

21238

(3006504) Eosinophils/100 leukocytes in Blood

3909

29240

1.48

66.12

5.9

5.7

2.8

0.31

3552

26687

(3022096) Basophils/100 leukocytes in Blood

3818

28471

1.47

65.34

6.0

5.7

0.6

0.18

3471

26020

(3018010) Neutrophils/100 leukocytes in Blood

3902

29296

1.47

64.04

5.8

5.6

60.4

59.3

6.15

3552

26764

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3494

25704

1.47

63.48

2.3

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1873

12279

1.56

57.95

2.7

2.4

11.1

11.6

umol/l

1.70

1645

11115

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1284

7687

1.68

57.59

4.4

3.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1742

11396

1.56

53.89

2.7

2.4

2.3

g/l

0.77

1524

10333

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1082

6326

1.70

52.69

4.1

3.8

1.2

mmol/l

2.87

879

5443

(3020682) Albumin/Creatinine [Ratio] in Urine

3042

22415

1.43

51.70

4.1

3.8

12.8

9.0

mg/mmol

2.11

1793

13734

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3939

30387

1.41

51.68

4.8

4.2

—

(3044889) 12 lead EKG panel

5432

44323

1.42

51.36

5.1

4.6

—

(3012516) Albumin [Mass/volume] in Urine

2885

21100

1.44

50.87

3.3

3.1

502.2

376.9

mg/l

0.64

1711

13103

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

881

4956

1.76

49.07

4.1

3.6

5.2

kpa

0.72

780

4502

(3009508) Creatinine [Moles/volume] in Urine

2884

21209

1.43

48.84

3.2

3.0

6.3

6.7

mmol/l

6.09

2218

17184

(3023520) Reticulocytes [#/volume] in Blood

1239

7651

1.62

48.52

2.5

2.4

67.3

67.5

e9/l

0.04

975

5806

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

846

4723

1.77

48.35

4.1

3.6

1.9

2.1

mmol/l

0.54

614

3509

(3018418) pH of Serum or Plasma

3061

22799

1.41

48.05

4.1

3.9

7.4

0.48

709

4059

(3009343) pH of Capillary blood

865

4893

1.75

47.17

4.2

3.6

7.4

1.61

124

614

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1630

10792

1.53

46.94

2.8

2.5

19.7

20.6

1.82

1285

8955

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1958

13572

1.47

44.78

1.7

1.5

1.6

mg/l

0.35

1539

10623

(3018095) Leukocytes [#/volume] in Urine

3360

25686

1.38

44.18

4.2

4.1

161.2

138.6

e6/l

0.45

2535

18663

(3027945) Reticulocytes/100 erythrocytes in Blood

1536

10195

1.52

43.33

2.3

1.8

1.08

1258

8805

(3002385) Erythrocyte distribution width [Ratio]

5613

46668

1.38

43.26

25.4

22.9

14.1

14.0

5.55

5455

45422

(1761868) Lipid panel - Serum or Plasma

1970

13755

1.46

43.14

3.7

3.5

—

(3019150) Specific gravity of Urine by Refractometry

2060

14585

1.44

41.65

5.6

5.0

1.0

kg/l

0.54

386

2321

(3000850) Epithelial cells [#/volume] in Urine

2239

16119

1.42

41.21

2.9

2.8

5.5

5.3

e6/l

0.20

1936

14076

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

646

3500

1.81

40.62

1.9

1.8

3.6

2.4

ug/l

0.57

531

2980

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

638

3450

1.81

40.37

2.1

2.0

—

(3021589) Normoblasts [#/volume] in Blood

3443

26717

1.36

39.99

13.3

10.4

0.0

e9/l

0.41

2881

21483

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2913

22055

1.37

39.38

5.9

5.7

4.4

4.5

ug/l

0.03

2482

19284

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

594

3185

1.82

38.61

1.9

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1197

7726

1.54

38.01

2.7

2.5

4.7

6.2

ug/l

4.83

940

6381

(3026782) Osmolality of Urine

2138

15448

1.41

38.00

3.2

3.0

514.5

540.6

mosm/kgh2o

7.83

1790

13070

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1461

9846

1.48

37.72

5.5

4.7

1.1

1.0

mmol/l

3.14

1290

8888

(3002582) Erythrocytes [#/volume] in Urine

2978

22747

1.36

37.63

3.7

3.6

172.4

96.8

e6/l

0.72

2352

17632

(3019225) pH of Specimen

1225

7989

1.52

37.00

5.2

4.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2328

17247

1.38

35.13

2.9

8526.3

7122.3

umol/l

0.55

1871

14246

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1372

9250

1.48

35.10

10.2

8.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

1192

7849

1.51

34.19

1.9

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

2733

20856

1.35

33.85

3.5

0.5

e6/l

0.52

2126

15970

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1524

10582

1.44

33.24

1.3

1.2

1.8

u/ml

0.02

391

2391

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1649

11676

1.41

32.13

2.7

0.8

mmol/l

0.35

1489

10623

(3022313) Gas panel - Capillary blood

612

3501

1.70

31.65

4.4

3.8

—

(40767503) Oxygen content in Capillary blood by calculation

347

1664

2.01

31.56

2.7

2.6

15.6

15.7

0.16

168

885

(3044640) Blood type and Crossmatch panel - Blood

2854

22171

1.32

30.50

2.7

2.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

702

4205

1.63

30.38

3.7

3.2

25.3

25.2

mmol/l

0.12

686

4090

(3017181) Myelocytes/100 leukocytes in Blood

870

5490

1.55

30.19

4.0

3.7

0.9

0.02

293

1688

(40761535) Cells panel - Urine sediment

992

6446

1.51

30.07

4.3

3.8

—

(3019060) Gas panel - Arterial blood

869

5494

1.55

29.89

4.2

4.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

273

1225

2.14

29.66

2.1

1.9

1.7

mmol/l

0.29

263

1193

(40768804) Tissue Pathology biopsy report

3163

25017

1.31

29.38

2.4

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

525

2939

1.73

29.34

4.7

4.1

24.8

25.0

mmol/l

0.56

454

2627

(3021440) Promyelocytes/100 leukocytes in Blood

827

5211

1.55

28.83

4.1

3.7

0.1

0.22

280

1576

(36304419) Bacteria [Presence] in Urine

2577

19861

1.32

28.73

3.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2074

15528

1.34

28.11

3.0

3.1

2.5

mmol/l

0.14

1812

13238

(3022217) INR in Platelet poor plasma by Coagulation assay

1733

12628

1.37

27.97

31.5

32.3

1.5

inr

0.65

257

1598

(3013290) Carbon dioxide [Partial pressure] in Blood

347

1738

1.93

27.85

4.7

4.3

5.1

5.0

kpa

0.37

337

1683

(3012501) Base excess in Blood by calculation

346

1737

1.92

27.58

4.7

4.3

2.8

2.9

mmol/l

0.31

242

1203

(3025159) Blasts/100 leukocytes in Blood

770

4822

1.56

27.55

4.1

3.7

0.1

0.4

1.27

235

1313

(3036481) Cortisol [Moles/volume] in Serum or Plasma

824

5241

1.54

27.49

2.0

2.1

376.8

384.9

nmol/l

0.46

718

4678

(3010421) pH of Blood

382

1985

1.86

27.39

4.8

4.1

7.4

0.70

338

1683

(3027315) Oxygen [Partial pressure] in Blood

347

1750

1.91

27.29

4.7

4.4

8.3

8.2

kpa

0.22

337

1694

(3002179) Metamyelocytes/100 leukocytes in Blood

783

4939

1.55

27.11

4.0

3.6

0.7

0.6

0.21

220

1193

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

913

5976

1.50

26.56

1.8

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

777

4926

1.54

26.27

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1337

9455

1.40

25.64

3.2

3.7

246.3

251.1

u/l

0.50

1217

8801

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

281

1350

2.00

25.47

1.2

1.3

151.4

175.2

titre

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

798

5129

1.52

25.28

6.4

6.0

24.6

mmol/l

0.10

748

4763

(3017732) Neutrophils [#/volume] in Blood

642

3950

1.58

24.74

3.4

4.1

4.3

e9/l

0.42

371

2688

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1340

9602

1.38

23.56

1.8

—

(3012544) pH of Venous blood

1140

7969

1.41

23.21

3.6

3.4

7.4

—

(3025941) Bacteria identified in Stool by Culture

512

3034

1.63

23.04

1.4

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1360

9828

1.37

22.60

2.0

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1336

9634

1.37

22.49

1.8

—

(3020891) Body temperature

527

3172

1.61

22.25

4.6

4.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

623

3918

1.54

21.75

4.4

4.0

45.3

46.4

0.59

616

3870

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1097

7704

1.40

21.65

3.7

3.4

5.9

5.8

kpa

0.28

1063

7449

(3002032) Base excess in Venous blood by calculation

1095

7696

1.40

21.50

3.7

3.4

2.2

2.0

mmol/l

0.85

894

6243

(3020630) Protein [Mass/volume] in Serum or Plasma

1026

7169

1.40

20.81

2.5

2.4

65.7

65.6

g/l

0.08

884

6267

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1196

8572

1.37

20.80

5.1

4.9

35.1

34.1

1.97

735

5338

(3015235) Bicarbonate [Moles/volume] in Capillary blood

375

2113

1.71

20.46

3.3

3.0

25.1

mmol/l

0.09

328

1838

(40768797) Stomach Pathology biopsy report

1215

8778

1.36

20.03

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

816

5519

1.44

19.84

2.1

1.8

235.6

165.2

ug/g

1.33

594

4155

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2238

17617

1.27

19.67

5.0

21.9

22.3

0.73

1292

9650

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

913

6312

1.41

19.64

3.4

3.3

98.9

95.5

ng/l

0.43

716

5204

(1616796) Gas panel - Central venous blood

323

1770

1.75

19.48

4.1

3.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2276

17971

1.27

19.46

3.0

35.4

35.7

u/l

0.04

2090

16736

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2138

16789

1.27

19.07

2.7

2.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

379

2192

1.66

18.77

1.5

1.6

273.0

266.5

titre

0.03

105

(3021901) Oxygen saturation in Capillary blood

292

1582

1.77

18.33

2.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

459

2802

1.58

18.26

2.7

—

(3037522) Nuclear Ab [Titer] in Serum

935

6571

1.39

18.21

1.4

1.3

583.0

525.0

titre

0.43

256

1536

(3007164) IgA [Mass/volume] in Serum or Plasma

1257

9261

1.33

18.05

1.5

2.8

2.7

g/l

0.83

694

4863

(3009445) Proteinase 3 Ab [Units/volume] in Serum

463

2856

1.56

17.61

1.5

34.7

20.5

u/ml

0.42

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

122

488

2.38

17.60

1.1

2.1

2.4

iu/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

782

5369

1.41

17.43

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

864

6036

1.39

17.41

2.4

2.3

—

(3016502) Oxygen saturation in Arterial blood

1138

8318

1.34

17.20

5.1

6.0

94.9

95.2

0.68

1086

7946

(3003396) Base excess in Arterial blood by calculation

1260

9347

1.32

17.18

5.1

5.8

1.2

mmol/l

0.00

960

7199

(3003338) MCHC [Mass/volume]

5325

46388

1.22

17.14

28.8

25.2

329.7

330.1

g/l

3.20

5257

45720

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

659

4405

1.45

17.01

2.7

2.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1538

11735

1.29

17.01

1.9

30.2

30.1

0.18

1474

11355

(3018405) Lactate [Moles/volume] in Arterial blood

459

2850

1.55

16.96

3.6

3.5

1.4

mmol/l

0.48

448

2794

(3028626) Oxygen [Partial pressure] in Capillary blood

322

1841

1.68

16.69

2.9

2.8

7.7

kpa

0.28

300

1696

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1136

8336

1.33

16.68

3.6

3.1

264.9

261.3

ng/l

0.08

1051

7628

(3000494) Fungus identified in Specimen by Culture

956

6844

1.36

16.53

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1258

9384

1.31

16.43

5.1

5.7

5.0

5.1

kpa

0.90

1180

8824

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

438

2712

1.56

16.39

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1257

9379

1.31

16.39

5.1

5.7

11.3

11.7

kpa

2.78

1182

8805

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

922

6582

1.36

16.22

2.1

2.0

0.2

g/l

1.10

826

6037

(3024354) Oxygen [Partial pressure] in Venous blood

897

6400

1.36

15.82

3.2

2.9

4.3

kpa

0.28

867

6162

(3022145) Colonoscopy Study observation

919

6612

1.35

15.34

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2024

16142

1.24

15.20

4.9

4.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1964

15613

1.24

15.19

4.9

4.3

238.5

413.3

ng/l

1.43

1730

13810

(3004119) Hemoglobin [Mass/volume] in Venous blood

722

5009

1.40

15.11

3.5

3.1

124.2

126.0

g/l

1.56

700

4881

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1164

8691

1.31

15.01

1.3

31.6

41.7

iu/ml

2.30

402

2658

(3030981) Hyaline casts [#/volume] in Urine by Automated count

609

4116

1.43

14.79

3.2

2.9

0.4

0.3

e6/l

0.34

599

4033

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

735

5146

1.38

14.55

3.3

2.9

53.2

57.0

ml/min/173m2

2.70

384

2329

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1889

15015

1.24

14.53

1.6

1.3

mmol/l

0.26

1409

12332

(3006184) Hemoglobin [Mass/volume] in Capillary blood

315

1865

1.62

14.29

2.4

2.3

127.1

125.1

g/l

0.70

232

1345

(3007930) Methemoglobin/Hemoglobin.total in Blood

517

3413

1.46

14.24

4.7

4.5

0.9

0.31

490

3201

(3043409) Potassium [Moles/volume] in Arterial blood

390

2434

1.54

14.11

3.8

3.7

3.8

3.9

mmol/l

1.05

368

2254

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

522

3467

1.45

13.93

4.7

4.5

1.6

1.09

494

3253

(3037121) Protein [Mass/volume] in Urine

413

2623

1.51

13.79

3.0

2.7

0.3

g/l

0.61

165

972

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

221

1207

1.75

13.59

3.3

3.4

59.7

59.3

0.15

221

1207

(3005719) IgG [Mass/volume] in Serum or Plasma

591

4040

1.41

13.47

2.9

2.7

10.7

10.6

g/l

0.15

527

3637

(3020779) Urea [Moles/volume] in Serum or Plasma

942

6936

1.32

13.37

7.2

5.6

12.7

11.6

mmol/l

3.75

862

6471

(3022621) pH of Urine by Test strip

696

4902

1.37

13.27

4.0

3.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

280

1645

1.63

13.13

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

256

1478

1.66

12.87

1.7

1.5

6.3

8.8

iu/ml

0.15

387

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

613

4267

1.39

12.56

5.2

5.8

24.6

25.0

mmol/l

1.69

605

4213

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

557

3841

1.40

12.07

2.8

2.4

0.7

2.79

537

3688

(3002173) Hemoglobin [Mass/volume] in Arterial blood

994

7486

1.29

11.87

5.6

6.4

117.6

118.9

g/l

1.23

960

7192

(4146454)

156

803

1.85

11.74

3.0

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1071

8177

1.27

11.45

1.3

1.2

17.5

16.8

u/ml

0.09

379

2616

(3028026) IgM [Mass/volume] in Serum or Plasma

474

3220

1.42

11.21

1.7

1.9

1.2

1.4

g/l

1.27

415

2832

(3014271) Vancomycin [Susceptibility]

134

670

1.91

11.05

3.3

3.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

382

2516

1.46

10.70

5.2

5.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1265

9936

1.24

10.52

5.2

5.7

103.9

104.2

mmol/l

1.48

1234

9689

(3047181) Lactate [Moles/volume] in Blood

361

2363

1.46

10.45

5.8

5.4

1.3

1.4

mmol/l

0.32

324

2084

(3004451) EKG impression Narrative

405

2.14

10.38

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

439

2988

1.41

10.29

2.6

3.0

49.1

90.8

mg/l

1.24

335

2433

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

438

2982

1.41

10.25

2.6

3.0

58.4

55.8

mg/l

0.06

338

2428

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

410

2759

1.43

10.25

2.1

596.8

562.7

ug/l

0.10

377

2592

(3003181) Sodium [Moles/volume] in Urine

263

1618

1.55

10.25

1.3

60.9

mmol/l

0.00

217

1289

(4034850)

320

2057

1.49

10.16

14.5

12.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

184

1040

1.69

10.12

1.3

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

426

2901

1.41

9.97

2.5

2.9

1.5

2.7

ratio

1.12

212

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

250

1535

1.56

9.84

1.4

1.3

—

(3000012) Reticulocyte production index

105

504

1.98

9.81

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

275

2.35

9.77

1.4

1.2

1.0

1.2

nmol/l

0.96

201

(40768443) Skin Pathology biopsy report

447

3081

1.39

9.75

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

253

1561

1.55

9.75

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

304

1953

1.49

9.70

1.2

1.1

168.6

258.4

titre

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

273

1716

1.52

9.67

2.4

2.2

130.1

94.1

ug/min

0.65

144

944

(3000570) Elastase.pancreatic [Mass/mass] in Stool

308

2003

1.47

9.26

1.4

253.4

265.1

ug/g

0.49

188

1217

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

196

1155

1.62

9.21

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

164

924

1.69

9.17

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1101

8644

1.23

9.13

3.0

3.7

20.0

21.7

ug/l

0.11

922

7177

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

173

991

1.66

9.09

1.3

—

(3042631) Mycobacterium sp identified in Specimen

195

1153

1.61

9.05

2.7

2.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

168

959

1.67

8.96

1.4

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

184

1076

1.63

8.93

2.2

2.1

29.5

27.9

mg/l

0.11

253

(3008757) Leukocyte morphology finding [Identifier] in Blood

151

850

1.69

8.51

3.7

4.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

214

1314

1.55

8.48

3.1

3.5

1.6

1.5

0.12

158

984

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

208

1269

1.56

8.48

1.3

1.2

6.1

4.8

u/ml

0.24

206

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

206

1255

1.57

8.46

1.3

1.2

36.2

4.0

u/ml

0.87

130

(3018572) Chloride [Moles/volume] in Blood

265

1708

1.48

8.37

6.2

6.0

104.7

104.8

mmol/l

0.16

241

1517

(3039000) Anion gap in Blood

265

1708

1.48

8.37

6.2

5.9

11.3

mmol/l

0.01

241

1517

(3037756) Immunofixation for Serum or Plasma

296

1950

1.45

8.36

1.4

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

597

4416

1.30

8.17

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

310

2072

1.43

8.12

1.5

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

216

1346

1.53

8.04

1.3

1.2

26.5

47.5

u/ml

0.80

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

171

1010

1.61

8.02

1.7

1.6

—

(4010399)

614

4571

1.29

8.00

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

237

1512

1.50

7.90

3.1

2.5

2.0

1.8

mg/l

1.50

202

1315

(3026389) Candida sp identified in Specimen by Organism specific culture

155

901

1.64

7.76

1.3

1.4

—

(3002256) Pathology report gross observation

1084

8640

1.21

7.71

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

282

1872

1.44

7.68

1.3

1.2

0.8

1.0

u/ml

0.13

179

(3000330) Specific gravity of Urine by Test strip

578

4293

1.29

7.68

4.5

4.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

327

2235

1.40

7.57

1.7

1.6

39.8

38.1

u/l

0.63

271

1850

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1497

12310

1.18

7.54

3.4

0.8

0.9

ug/l

0.27

1114

9086

(3027456) Digoxin [Moles/volume] in Serum or Plasma

382

2681

1.36

7.53

3.4

3.3

0.9

0.8

nmol/l

1.14

304

2065

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

179

1088

1.57

7.47

1.2

4.0

8.4

u/ml

0.86

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

117

638

1.75

7.44

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

314

2141

1.40

7.38

1.7

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

141

818

1.64

7.15

3.1

3.5

62.4

58.9

0.83

498

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

191

1193

1.53

7.08

3.7

2.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

546

4071

1.29

7.06

1.5

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

532

3955

1.29

7.03

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

428

1.89

7.03

3.6

—

(3003694) ABO and Rh group [Type] in Blood

1693

14136

1.16

7.01

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

163

987

1.57

6.95

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

209

1337

1.49

6.93

2.0

2.1

33.0

31.6

umol/l

0.34

155

1065

(3019832) Treponema pallidum Ab [Presence] in Serum

169

1033

1.56

6.92

1.4

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

157

944

1.58

6.90

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

195

1231

1.51

6.89

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1572

13070

1.17

6.86

3.0

1.3

1.4

e6/l

0.17

980

7586

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

234

1534

1.46

6.86

2.0

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

118

661

1.70

6.86

1.4

1.5

13.9

13.4

u/l

0.37

113

630

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

153

916

1.59

6.85

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

154

928

1.58

6.72

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

230

1512

1.45

6.66

1.8

1.4

0.2

g/l

0.26

218

1401

(3025468) Yersinia sp identified in Specimen by Organism specific culture

153

923

1.58

6.65

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

320

2231

1.37

6.62

2.7

3.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

445

1.84

6.57

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

569

4305

1.27

6.55

1.6

1.5

1.6

g/l

0.58

473

3641

(40758558) Short blood count panel - Blood

1920

16264

1.15

6.48

6.0

6.4

—

(3049717) Cytology report of Urine Cyto stain

472

3495

1.29

6.46

2.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

923

1.57

6.44

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

631

4844

1.25

6.42

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

152

925

1.56

6.38

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

704

1.65

6.37

1.3

—

nmol/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

177

1116

1.51

6.33

1.2

9.7

0.6

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

430

3159

1.30

6.25

3.2

3.1

4.3

pmol/l

0.31

351

2687

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

233

1555

1.43

6.25

1.8

1.4

1.1

1.2

g/l

1.80

221

1443

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

496

1.76

6.17

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

878

7006

1.21

6.16

4.4

5.3

1.4

mmol/l

0.11

834

6688

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

134

801

1.59

6.09

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

201

1314

1.46

6.03

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

119

695

1.63

5.96

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

235

1592

1.41

5.82

2.9

2.8

257.1

709.7

u/ml

1.48

210

1434

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

213

1418

1.43

5.82

1.8

1.7

13.1

12.5

mg/l

0.10

193

1262

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

415

1.81

5.80

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

592

1.67

5.77

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

592

1.67

5.77

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

592

1.67

5.77

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

182

2.24

5.73

1.2

—

(3045424) Erythrocytes [Presence] in Urine

166

1058

1.49

5.68

1.5

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

252

2.03

5.63

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

298

1.94

5.60

1.1

1.2

1.0

0.9

promille

0.17

226

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

420

1.79

5.59

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

421

1.78

5.55

1.4

—

(3045414) Leukocytes [Presence] in Urine

404

2995

1.29

5.53

2.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

478

1.73

5.51

1.2

20.5

45.2

u/ml

—

(44813793)

248

2.03

5.50

1.0

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

132

807

1.56

5.49

1.3

0.7

nmol/l

0.22

124

767

(3000991) Gas panel - Venous blood

822

6590

1.20

5.49

5.3

6.4

—

(3044927) Protein electrophoresis panel - Urine

152

960

1.51

5.46

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

308

2208

1.33

5.39

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

142

888

1.52

5.35

1.6

1.5

62.4

63.2

0.09

552

(3040151) Glucose [Moles/volume] in Capillary blood

158

1011

1.49

5.33

7.9

8.1

7.5

7.3

mmol/l

0.29

132

822

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

131

806

1.55

5.31

1.3

0.2

0.3

nmol/l

1.13

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

352

2579

1.30

5.28

1.1

1.2

102.3

123.6

iu/ml

0.58

117

854

(21494815) CD4 cells/100 lymphocytes in Specimen

371

1.79

5.04

1.9

45.0

35.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

571

1.63

5.02

1.1

—

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

454

3458

1.26

5.01

2.1

2.2

3.8

g/l

0.52

276

2369

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

267

1897

1.34

4.99

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

232

2.00

4.96

1.2

1.3

16.2

11.3

umol/l

0.31

161

(3022493) Free Hemoglobin [Mass/volume] in Plasma

285

1.90

4.94

1.1

3.0

71.7

68.6

mg/l

0.10

194

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.26

4.94

2.4

5.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

454

3467

1.25

4.90

2.1

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

754

1.54

4.89

2.8

2.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

627

1.59

4.88

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

454

3473

1.25

4.83

2.1

2.2

7.6

g/l

0.40

293

2458

(3014007) Fractional oxyhemoglobin in Arterial blood

617

4883

1.21

4.75

5.6

7.1

93.2

93.7

0.85

611

4862

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

147

952

1.47

4.72

1.3

281.8

417.3

u/l

1.32

134

895

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

154

1007

1.45

4.71

4.3

3.8

323.6

3321.4

iu/ml

0.96

141

(3043410) Blood group antigens tested for on Red Blood Cells

192

2.07

4.69

1.5

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

336

2489

1.29

4.68

1.3

193.8

232.4

u/ml

0.47

306

2233

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

113

694

1.55

4.67

1.2

236.4

255.7

pmol/l

0.45

521

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.37

4.60

1.1

0.7

1.1

u/field

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

355

1.76

4.57

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

355

1.76

4.57

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

355

1.76

4.57

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

109

2.44

4.55

1.0

1.1

1760.3

1651.9

miu/ml

0.18

109

(3011412) CD3 cells [#/volume] in Blood

462

1.66

4.55

2.0

1.9

0.9

1.1

e9/l

0.84

292

(3010503) CD19 cells [#/volume] in Blood

321

1.80

4.54

2.0

0.1

e9/l

0.09

301

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

271

1959

1.32

4.54

1.5

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

356

1.76

4.53

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

427

1.69

4.52

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

427

1.69

4.52

1.3

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

3.58

4.40

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

119

751

1.51

4.37

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

616

1.56

4.34

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

118

746

1.50

4.31

1.3

13.0

u/l

0.00

107

672

(3041918) Cholesterol [Moles/volume] in Pleural fluid

167

2.10

4.30

1.1

1.2

1.5

mmol/l

1.32

100

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

287

1.82

4.23

1.5

5.1

6.6

u/l

1.29

234

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

472

1.63

4.22

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

315

1.78

4.22

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

148

985

1.43

4.17

1.3

1.4

0.8

nmol/l

0.24

115

812

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

446

3465

1.23

4.17

1.7

1.5

1.7

1.6

1.40

350

2766

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

117

745

1.49

4.14

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

170

2.06

4.12

1.9

2.3

7.2

7.4

mmol/l

0.06

114

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1434

12251

1.13

4.11

3.3

3.2

3.3

3.0

e6/l

0.28

854

6832

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

1.98

3.97

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

140

932

1.43

3.96

6.3

5.9

12.7

12.6

mg/l

0.11

122

821

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

162

1107

1.39

3.95

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.54

3.94

1.1

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

387

1.67

3.91

2.2

1.9

15.6

26.5

umol/l

—

(3000285) Sodium [Moles/volume] in Blood

118

2.25

3.87

1.5

1.1

—

(36660697) Celiac disease serology panel - Serum

485

3836

1.21

3.82

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

374

2881

1.24

3.81

1.3

53.3

52.5

au/ml

0.02

117

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

169

1173

1.37

3.77

1.1

34.9

14.9

u/ml

—

(3051593) INR in Capillary blood by Coagulation assay

495

1.57

3.74

10.9

12.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

410

3198

1.22

3.72

2.1

2.2

3.1

g/l

0.34

284

2409

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

611

4949

1.18

3.70

5.6

6.9

1.4

1.3

1.72

600

4905

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

609

4933

1.18

3.69

5.6

7.0

0.7

0.95

598

4891

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

107

687

1.48

3.68

1.4

1.3

—

(3006270) Folate [Moles/volume] in Blood

112

726

1.47

3.68

1.2

271.9

313.0

nmol/l

1.39

532

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

2.08

3.58

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

435

1.59

3.54

1.3

0.4

0.5

g/l

0.32

317

(3028192) IgG subclass 2 [Mass/volume] in Serum

435

1.59

3.54

1.3

2.9

g/l

0.10

317

(3027135) IgG subclass 1 [Mass/volume] in Serum

435

1.59

3.54

1.3

6.8

7.1

g/l

0.30

311

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

118

2.17

3.45

1.1

1.2

35.6

357.9

u/l

0.58

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.90

3.44

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

137

937

1.39

3.39

2.3

2.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

113

2.18

3.37

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

114

756

1.43

3.36

1.2

1.3

28.2

54.9

mu/l

2.92

661

(3004775) Volume in Urine collected for unspecified duration

585

1.49

3.36

2.5

2.1

664.8

643.2

0.20

370

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

332

1.66

3.32

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

229

1698

1.28

3.28

4.8

3.8

30.9

30.2

mg/l

0.10

143

1135

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

131

895

1.39

3.27

1.3

1.2

34.1

54.9

u/ml

1.24

104

(3017446) Testosterone [Moles/volume] in Serum or Plasma

381

2994

1.21

3.26

2.0

11.7

10.6

nmol/l

1.19

293

2498

(3016750) Collection duration of Urine

401

1.59

3.22

2.1

2.0

488.3

499.8

min

0.41

287

(3003434) Protein [Mass/volume] in Pleural fluid

196

1429

1.30

3.20

1.4

1.5

29.4

30.9

g/l

0.96

183

1249

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

236

1.77

3.18

1.5

1.4

20.0

22.2

0.22

193

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

2.12

3.18

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

412

3271

1.20

3.17

2.1

2.2

10.5

10.2

g/l

0.56

318

2643

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

111

743

1.42

3.13

2.0

2.4

2.8

2.2

u/field

0.27

248

(3039162) Centromere protein B Ab [Units/volume] in Serum

595

1.47

3.12

1.3

1.2

38.8

53.4

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

176

1270

1.32

3.11

1.3

1.5

1875.9

2192.5

e6/l

0.14

135

899

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

107

713

1.43

3.10

1.2

1.1

63.2

61.9

u/l

0.04

479

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

183

1.86

3.10

1.1

1.2

1.1

ratio

0.57

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

347

1.61

3.06

2.0

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

157

1.93

3.06

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

174

1257

1.32

3.06

1.2

1.1

63.3

128.5

titre

2.19

(3021788) Differential panel - Synovial fluid

182

1324

1.31

3.04

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

119

812

1.39

3.02

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

476

3846

1.18

3.02

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

371

1.59

3.01

1.4

68.0

67.4

0.04

296

(3024980) IgG subclass 4 [Mass/volume] in Serum

105

702

1.42

3.00

1.3

1.6

0.9

0.8

g/l

0.17

536

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

292

1.66

2.95

1.4

1.3

1.2

u/ml

0.04

161

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

618

1.44

2.95

1.6

1.5

—

(3035880) pH of Pleural fluid

548

1.47

2.94

1.2

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

235

1.73

2.94

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

114

777

1.39

2.93

1.4

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

187

1.82

2.91

1.9

1.8

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.99

2.91

1.2

1.0

1.3

u/field

—

(3016038) Potassium [Moles/volume] in Urine

605

1.44

2.89

1.1

30.7

35.3

mmol/l

1.69

488

(3008295) Osmolality of Serum or Plasma

109

740

1.40

2.87

1.4

1.3

278.1

274.5

mosm/kgh2o

0.90

520

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

140

990

1.34

2.87

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

202

1.78

2.86

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

431

1.52

2.80

1.3

1.2

1.5

nmol/l

0.09

387

(3036525) Urea [Moles/time] in 24 hour Urine

2.91

2.80

3.0

3.8

—

(3034770) Mitochondria Ab [Titer] in Serum

175

1284

1.30

2.78

1.2

1.1

621.7

1008.6

titre

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.28

2.77

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

320

1.60

2.75

1.2

187.8

276.3

u/l

0.85

302

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

699

1.40

2.74

1.4

207371.7

194819.5

e6/l

0.04

472

(4062490)

441

1.51

2.74

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

652

1.41

2.72

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

351

1.57

2.72

1.8

18.8

14.9

0.99

129

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

234

1792

1.24

2.63

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

237

1818

1.24

2.63

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

281

1.62

2.59

1.9

—

(44790049)

659

1.40

2.58

1.3

—

(44790047)

659

1.40

2.58

1.3

—

(44806118)

659

1.40

2.58

1.3

—

(44790048)

659

1.40

2.58

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

237

1823

1.24

2.57

1.3

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.19

2.56

1.4

1.5

46.4

47.7

umol/l

0.09

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

127

1.94

2.56

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

224

1.69

2.55

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

210

1.72

2.54

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

165

1218

1.29

2.54

1.6

6.2

4.8

iu/l

0.54

350

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

350

1.54

2.53

1.2

1.1

29.8

34.4

u/l

0.28

249

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

137

987

1.32

2.52

1.1

—

(3019977) pH of Arterial blood

489

1.46

2.51

2.1

2.3

7.4

0.01

182

(3003327) Ova and parasites identified in Stool by Light microscopy

195

1473

1.26

2.49

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

352

1.54

2.47

1.2

1.1

102.4

91.3

u/l

0.36

257

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

207

1.69

2.39

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

207

1.69

2.39

1.9

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

263

2063

1.21

2.39

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

232

1798

1.23

2.37

1.7

1.6

14179.0

15423.8

e6/l

0.21

189

1251

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

187

1.72

2.34

1.5

1.4

18.5

16.8

pmol/l

0.77

144

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

153

1.80

2.29

1.2

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.92

2.27

1.2

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

5.92

2.27

1.0

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

127

921

1.31

2.27

1.3

1.4

6.7

6.4

mmol/l

0.62

121

845

(3011335) Digoxin [Mass/volume] in Serum or Plasma

113

1.93

2.25

3.1

2.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

292

1.56

2.25

2.0

516.3

503.0

e6/l

0.06

249

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

1.89

2.24

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

109

775

1.33

2.24

3.7

3.6

325.8

329.4

umol/l

0.09

630

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

686

1.36

2.23

1.5

24.6

27.2

0.35

434

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

114

1.91

2.20

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

135

993

1.29

2.18

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

213

1.65

2.18

1.4

18.7

22.2

umol/l

0.36

202

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

107

765

1.33

2.13

1.7

23.2

27.5

u/ml

0.57

172

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

289

1.54

2.12

1.1

1.2

—

(3016228) CD19 cells/100 cells in Blood

222

1.62

2.12

1.9

1.8

8.7

7.2

0.36

210

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

109

1.91

2.12

2.4

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

659

5604

1.12

2.11

1.3

—

(3017704) Immunofixation for Urine

476

1.41

2.10

1.5

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

137

1.80

2.09

2.2

2.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

613

1.36

2.08

1.1

1.6

g/l

0.32

537

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

110

1.89

2.07

2.4

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

277

1.54

2.04

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

277

1.54

2.04

1.9

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

154

1164

1.26

2.03

1.3

1.5

35695.0

63931.2

e6/l

1.55

678

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

162

1234

1.25

2.00

1.4

1.3

44.3

42.5

u/l

0.07

127

1064

(3001893) Eosinophils/100 leukocytes in Pleural fluid

317

1.50

1.99

1.3

1.4

0.8

2.7

3.75

261

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

201

1568

1.22

1.99

1.9

2.2

3.7

3.6

g/l

0.31

188

1475

(3036670) Protein [Mass/volume] in Synovial fluid

264

1.54

1.98

1.3

1.2

39.7

40.3

g/l

0.09

124

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

660

1.34

1.97

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

287

1.52

1.97

1.1

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1913

17138

1.07

1.94

3.8

3.9

82.8

0.01

1869

16695

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

500

1.38

1.94

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

858

7439

1.10

1.93

2.5

9.3

9.8

umol/l

0.29

712

6379

(40757373) Influenza virus identified in Isolate

185

1.64

1.89

1.4

—

(4015189)

222

1.58

1.89

2.5

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.96

1.88

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

200

1.61

1.88

1.2

—

(3000492) Spirometry study

509

4300

1.13

1.86

1.5

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.02

1.82

1.0

2.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

130

1.75

1.80

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.58

1.79

1.0

1.1

—

mmol/l

—

(4035726)

712

6143

1.11

1.79

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

413

1.40

1.76

2.0

2.1

2.2

1.8

u/field

0.18

272

(3017569) Oxygen content in Arterial blood

422

1.39

1.74

1.9

2.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.03

1.73

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

205

1.57

1.72

1.4

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

142

1087

1.24

1.72

1.4

201.9

262.4

pmol/l

0.76

133

1047

(4024509)

113

843

1.27

1.71

1.8

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

305

1.46

1.71

2.2

2.1

741.5

536.9

e6/l

0.50

128

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.97

1.71

1.1

1.2

5043.6

169.0

ng/l

0.47

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

545

1.34

1.71

1.1

—

18.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

105

777

1.28

1.70

1.5

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

491

4166

1.12

1.69

6.8

7.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

298

1.46

1.69

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

222

1782

1.18

1.67

1.5

—

(40768441) Liver Pathology biopsy report

362

1.41

1.66

1.1

1.2

—

(3048879) Bone marrow aspiration report

276

1.48

1.66

1.3

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

155

1205

1.22

1.64

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

782

1.27

1.63

2.3

2.0

188.5

1908.7

u/ml

1.30

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.76

1.61

2.4

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

135

1037

1.24

1.61

1.6

1.7

18.6

23.8

ug/l

1.30

130

1005

(3048929) Epstein Barr virus Ab [Presence] in Serum

111

836

1.26

1.58

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.22

1.57

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.22

1.57

1.2

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.99

1.56

13.0

12.3

640.0

158.0

e6/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

375

1.39

1.56

2.9

3.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

235

1.49

1.52

1.9

2.0

881.4

1773.0

u/ml

2.21

227

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

152

1.62

1.52

1.1

—

7.8

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

183

1459

1.19

1.52

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

306

1.42

1.50

1.3

11.6

343.2

ug/l

1.80

166

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.17

1.50

1.4

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.87

1.50

1.4

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

120

919

1.24

1.49

1.5

1.2

—

(3025577) Chromium [Mass/volume] in Blood

534

1.31

1.48

1.9

2.0

1.7

2.2

ug/l

1.16

445

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

206

1.52

1.48

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.44

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

200

1.52

1.43

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

414

1.35

1.43

1.3

1.2

108.2

90.7

u/l

0.59

360

(4094501)

184

1477

1.18

1.43

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

546

1.30

1.42

1.8

1.9

4.3

3.8

ug/l

0.26

475

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.70

1.41

1.2

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

435

3713

1.11

1.40

3.3

3.5

24.1

24.2

mmol/l

0.25

377

3300

(44816559) Phosphatidylethanol [Mass/volume] in Blood

606

1.28

1.39

1.4

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

281

1.42

1.36

3.0

2.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

509

1.30

1.35

1.4

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.78

1.32

6.8

4.9

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

139

0.48

1.32

2.7

8.2

13.2

13.7

—

139

(3042111) Morphology [Interpretation] in Bone marrow Narrative

172

1385

1.18

1.31

1.2

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

260

1.42

1.30

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

167

1.53

1.29

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

152

1.56

1.28

1.7

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

296

2490

1.13

1.25

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

608

1.26

1.24

1.3

1.1

303.8

296.0

u/ml

0.07

367

(44786800) Granulocytes/100 leukocytes in Body fluid

146

1.56

1.23

1.3

1.4

27.2

22.3

0.27

113

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

402

1.32

1.21

1.3

1.2

26.5

29.7

u/l

0.24

338

(21494890) Protein electrophoresis panel - 24 hour Urine

113

884

1.21

1.20

1.7

1.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

226

1.43

1.17

2.0

64.0

57.6

umol/l

0.50

165

(4306422)

515

0.73

1.16

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

139

1114

1.18

1.15

1.4

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

149

1.53

1.15

1.1

1.2

231.1

279.1

pmol/l

0.54

101

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

448

1.29

1.13

1.9

1.8

196.9

180.8

pmol/l

0.68

404

(3047007) Chlamydophila sp Ab [Presence] in Serum

457

1.29

1.12

1.3

1.2

—

(4133840)

1.68

1.12

1.4

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.68

1.12

18.1

12.5

4.9

5.3

mmol/l

0.26

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

109

0.43

1.12

1.0

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

166

1.48

1.10

1.3

1.5

7.4

8.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.89

1.10

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

619

1.24

1.10

1.0

1.1

198.6

477.2

iu/ml

0.28

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.78

1.10

1.0

—

(3006462) Nitrate [Presence] in Urine

368

1.31

1.09

5.2

4.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.21

1.08

1.0

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

214

1.42

1.08

1.1

12.3

11.5

iu/ml

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.94

1.07

1.3

1.2

—

(44806071)

1.94

1.07

1.3

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

342

2933

1.11

1.07

2.3

1.2

1.1

g/l

0.02

263

2405

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

665

1.23

1.06

1.5

1.2

122.8

119.1

u/ml

0.16

137

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

370

1.31

1.05

1.0

—

(3036603) Volume of Urine

413

1.28

1.03

1.3

1.5

1577.4

1774.7

0.49

127

(40768806) Pleura Pathology biopsy report

136

1102

1.17

1.02

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

499

1.25

1.00

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

242

1.37

1.00

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

242

1.37

1.00

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

654

1.22

0.99

3.6

2.9

48.4

27.4

mg/l

0.56

487

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

284

1.33

0.97

2.1

2.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

529

0.77

0.96

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

188

1.41

0.95

1.9

2.0

159685.0

54206.5

u/ml

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

386

1.28

0.93

1.3

1.2

2.1

2.2

mmol/l

0.68

351

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

181

1.41

0.93

1.4

1.3

37.1

29.9

0.48

119

(4211845)

395

1.27

0.92

5.1

4.1

—

(3024263) Appearance of Synovial fluid

395

1.27

0.92

1.9

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

134

1.48

0.92

1.1

1.3

40.7

73.1

mu/l

1.14

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

339

2934

1.10

0.92

3.7

3.9

118.3

98.7

u/ml

0.19

325

2790

(3009015) Lactate [Moles/volume] in Synovial fluid

1.64

0.91

1.4

1.2

5.4

6.4

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

651

0.80

0.91

1.1

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

338

1.29

0.90

1.6

1.4

2.2

3.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

231

1.35

0.89

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

857

0.83

0.89

1.7

1.5

—

(4212803)

0.49

0.89

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

199

1678

1.12

0.89

2.5

2.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.89

0.88

1.0

—

(4198724)

1.89

0.88

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.62

0.88

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.03

0.87

1.0

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

152

1.43

0.86

1.8

1.4

127.6

126.0

ng/l

0.02

152

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.64

0.86

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

274

1.31

0.86

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

641

1.20

0.84

1.6

1.3

316.4

289.0

titre

0.06

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

177

1.39

0.84

1.2

1.1

1.2

u/l

—

(3008898) HLA-B27 [Presence]

104

842

1.17

0.84

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.76

0.83

1.1

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

218

1.35

0.83

1.4

1.5

68.2

92.8

umol/l

0.78

127

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

128

1388

0.87

0.83

1.9

1.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

505

1.22

0.82

1.8

282.8

333.7

mu/l

0.81

462

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

618

1.20

0.81

1.6

1.3

54.0

58.5

titre

—

(3044290) Cell count panel - Cerebral spinal fluid

116

952

1.15

0.80

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.68

0.79

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.60

0.79

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.56

0.78

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

116

1.47

0.78

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

522

0.80

0.77

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

322

1.26

0.76

5.1

6.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

222

1.32

0.75

1.0

1.1

317.3

296.6

mg/l

0.25

195

(3035637) Corticotropin [Mass/volume] in Plasma

641

1.18

0.75

1.2

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

231

1.31

0.74

3.2

2.9

29.9

28.7

umol/l

0.28

172

(3032868) Hemoglobin electrophoresis panel in Blood

2.06

0.74

1.2

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.06

0.74

1.2

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.06

0.74

3.4

3.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

174

1.36

0.73

3.0

2.5

—

(3012565) Volume of 24 hour Urine

307

1.26

0.73

2.3

1596.8

1787.0

0.54

252

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

131

1402

0.88

0.73

2.4

2.2

213.5

212.9

0.02

125

1315

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

188

1604

1.11

0.72

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

139

1166

1.13

0.72

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

311

2721

1.08

0.71

2.1

36.8

g/l

0.06

232

2213

(3051611) Lipemic interference index of Serum or Plasma

105

865

1.15

0.71

3.3

3.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

334

1.25

0.71

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

334

1.25

0.71

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

275

1.27

0.70

2.2

2.6

40.9

37.4

0.37

106

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

420

1.22

0.70

1.4

1.5

5.5

7.7

u/l

0.50

200

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

335

1.24

0.69

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.60

0.68

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.66

0.68

1.1

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

1.39

0.68

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

807

1.15

0.67

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

128

1.41

0.67

1.2

2.1

2.0

mmol/l

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

685

6170

1.05

0.67

2.3

66.1

36.8

u/l

0.46

581

5201

(3020491) Glucose [Moles/volume] in Blood

474

1.20

0.67

2.0

2.4

7.6

7.2

mmol/l

0.59

324

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

143

1209

1.12

0.66

1.3

1.2

572.3

585.7

mg/l

0.10

133

1132

(3006576) Bicarbonate [Moles/volume] in Blood

261

1.27

0.66

7.7

6.0

25.3

24.8

mmol/l

0.29

232

(3020650) Glucose [Presence] in Urine

113

1.42

0.65

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

228

1.29

0.65

2.9

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

416

1.21

0.64

4.3

5.0

235.2

133.6

u/ml

0.38

123

(1002224) Polysomnography panel

113

944

1.13

0.64

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

445

0.81

0.63

1.6

1.4

—

(4027681)

155

1.34

0.62

1.1

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

363

3218

1.07

0.62

2.3

2.6

0.4

u/ml

0.47

220

1844

(3009214) Lutropin [Units/volume] in Serum or Plasma

576

1.17

0.61

1.3

15.5

13.1

u/l

0.58

457

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

124

1047

1.12

0.61

1.3

1.2

3.9

3.8

mmol/l

0.11

111

966

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.48

0.60

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

333

1.22

0.60

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

333

1.22

0.60

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.58

0.60

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.40

0.60

1.0

1.2

82.6

80.4

0.13

(44806420)

316

1.23

0.60

2.3

2.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

156

1.34

0.60

1.1

0.7

umol/24h

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

334

1.22

0.59

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.58

0.0

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

553

1.16

0.58

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

457

1.18

0.57

1.2

—

(3014891) Appearance of Pleural fluid

174

1.31

0.57

1.8

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.48

0.57

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.48

0.55

1.3

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.43

0.55

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.43

0.55

2.4

2.0

65.2

134.4

nmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

618

1.15

0.55

2.1

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.52

0.54

1.7

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

134

1.34

0.54

7.5

7.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

478

4301

1.05

0.53

5.5

7.0

24.3

24.5

mmol/l

0.59

431

3908

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

727

1.13

0.53

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

479

1.17

0.53

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

160

1.30

0.52

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

152

1.31

0.52

2.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

494

0.84

0.51

1.2

1.1

123.4

114.6

0.84

415

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

463

0.84

0.51

1.0

48.2

46.0

ng/l

0.12

285

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

463

0.84

0.51

1.0

702.8

664.3

ng/l

0.16

276

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

120

1.34

0.49

1.8

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

145

1.31

0.49

1.9

1.8

9.5

10.9

0.15

127

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

461

0.84

0.49

1.0

353.1

333.8

ng/l

0.21

288

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

144

1489

0.91

0.49

2.0

88.8

87.6

0.25

134

1401

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

653

1.13

0.47

1.6

53.0

49.7

nmol/l

0.50

613

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.47

0.47

1.1

—

(40762814) Titanium [Mass/volume] in Blood

155

1.28

0.46

1.8

2.0

8.3

3.7

ug/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

486

1.15

0.46

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

241

1.22

0.45

1.1

52.4

42.8

mg/l

0.54

206

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.41

0.45

1.6

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

173

1516

1.08

0.45

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

1.40

0.45

2.5

1.6

75.0

2537.1

e6/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

381

1.17

0.45

2.0

2.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.35

0.43

5.9

3.0

35.7

40.3

umol/l

—

(21494434) Karyotype in Bone marrow

695

1.12

0.43

1.1

—

(3045788) Cell count panel - Pleural fluid

114

985

1.10

0.42

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

167

1468

1.08

0.41

1.1

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.34

0.41

1.2

1.1

16.5

g/l

0.01

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

338.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.35

0.40

2.1

1.8

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.48

0.40

1.0

1.2

379.0

799.4

u/l

—

(3022689) Creatine [Moles/volume] in Urine

150

1.26

0.40

1.7

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

125

1.29

0.39

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

545

4967

1.04

0.39

1.4

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

440

1.14

0.39

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

1.34

0.38

1.2

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.34

0.38

1.2

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.35

0.38

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

143

1.26

0.38

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

247

1.19

0.37

2.1

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

247

1.19

0.37

2.2

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

427

0.86

0.37

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

427

0.86

0.37

1.3

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

152

1.25

0.37

1.4

1.2

193.8

139.4

nmol/l

0.84

107

(3045142) Bone marrow Pathology biopsy report

802

1.10

0.37

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

640

1.11

0.36

1.3

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

292

1.17

0.36

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.27

0.36

1.4

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.46

0.36

4.7

4.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

228

2041

1.06

0.35

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

228

2041

1.06

0.35

1.3

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1.32

0.33

8.0

14.6

1139.6

1350.1

nmol/l

0.47

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.32

0.33

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

146

1.23

0.33

1.1

—

(40765096) Chromosome analysis panel by Banding

209

0.81

0.33

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.35

0.31

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

207

0.82

0.31

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.72

0.31

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

952

0.92

0.30

1.7

1.6

2.5

3.4

mg/l

0.67

718

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

209

1.18

0.30

2.5

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

316

1.14

0.29

1.4

1.3

40.7

38.6

iu/l

0.12

272

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.25

0.29

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.25

0.29

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.25

0.29

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.23

0.29

1.0

1.2

7.3

10.6

u/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

327

1.13

0.27

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

116

1028

1.07

0.27

1.4

1.3

108.4

26.8

e6/l

0.38

800

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.23

0.27

1.0

1.3

90.9

79.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

132

0.79

0.27

1.2

2.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.20

0.27

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

194

1.17

0.27

1.1

418.6

772.5

ng/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

116

1029

1.07

0.27

1.5

1.4

616.9

1017.2

e6/l

0.63

848

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

283

1.14

0.27

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.26

0.27

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.27

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.29

0.26

2.1

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

239

1.15

0.26

10.5

4.6

68.8

70.5

0.13

188

(3023487) Leukocytes [#/volume] in Peritoneal fluid

231

1.15

0.25

1.5

2.0

2095.1

4740.0

e6/l

0.32

157

(3001964) Herpes simplex virus Ag [Presence] in Specimen

161

0.82

0.25

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

421

1.10

0.24

1.1

231.6

177.6

miu/ml

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

341

0.89

0.24

1.1

1.2

12.8

12.2

mmol/l

0.18

(3011288) Drugs identified in Urine by Screen method

100

1.23

0.23

2.1

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

439

0.90

0.23

1.1

1.2

145.0

135.0

titre

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

287

1.12

0.23

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.28

0.23

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

497

0.91

0.22

3.5

2.6

—

(3033799) Differential panel - Peritoneal fluid

216

1.14

0.22

1.4

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

243

1.13

0.22

1.3

1.2

6.1

6.3

mmol/l

0.26

225

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

136

1.18

0.22

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

117

1048

1.06

0.22

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

65.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.4

—

10.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.18

0.21

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.18

0.21

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

316

1.11

0.21

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

485

0.92

0.21

1.1

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.3

—

(3052851) Hemolysis interference index of Serum or Plasma

270

2472

1.03

0.20

3.9

3.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

146

1.17

0.20

1.2

29.2

27.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

146

1.17

0.20

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.26

0.20

1.2

1.1

—

0.5

—

(3034426) Prothrombin time (PT)

126

0.83

0.19

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

882

0.94

0.19

3.3

3.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.16

0.19

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

1.16

0.19

1.3

1.1

—

(40768793) Breast Pathology biopsy report

156

1416

1.04

0.19

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

210

1.13

0.19

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

112

1.18

0.18

4.7

3.9

54.4

36.5

u/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

115

0.82

0.18

1.0

1.2

—

(3016879) Cocaine [Presence] in Urine

139

1.16

0.18

1.2

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.21

0.17

5.9

7.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

1.13

0.16

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.18

0.16

2.1

2.5

—

68.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.18

0.16

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

274

2523

1.03

0.16

2.2

0.1

0.0

g/l

0.37

244

2237

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

340

1.09

0.16

1.1

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

249

1.10

0.16

1.2

1.4

67.7

60.3

0.67

214

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.18

0.15

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.10

0.15

1.1

1.8

1.7

umol/24h

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.79

0.15

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.78

0.15

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

123

1.15

0.15

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

141

1.14

0.15

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.12

0.15

1.8

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

692

1.05

0.15

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

669

0.95

0.14

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

1.13

0.14

1.1

—

(4281824)

703

1.05

0.14

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

491

1.06

0.13

1.2

7.7

8.1

mmol/l

0.66

312

(40768795) Lymph node Pathology biopsy report

640

1.05

0.13

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

143

1.13

0.13

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

102

0.83

0.13

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

107

1.15

0.13

6.2

7.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

0.86

0.12

1.0

—

(3036489) Thrombin time

217

2102

0.98

0.12

1.9

1.8

22.7

22.0

0.37

197

1911

(3029075) Extractable nuclear Ab panel - Serum

126

1.13

0.11

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

117

1.13

0.11

1.2

1.3

34.8

116.1

ug/l

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

384

1.06

0.11

2.0

2.2

41.4

75.8

ug/min

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

145

1.11

0.10

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

145

1.11

0.10

1.1

—

(3027008) Opiates [Presence] in Urine

145

1.11

0.10

1.2

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

145

1.11

0.10

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

145

1.11

0.10

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

127

1.12

0.10

1.8

1.6

9.9

ug/l

0.02

127

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

296

2849

0.98

0.10

2.3

3.0

10123.2

1944.5

u/ml

0.44

244

2378

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.15

0.10

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

254

2360

1.02

0.09

2.2

0.0

g/l

1.25

225

2083

(3028300) Cannabinoids [Presence] in Urine

146

1.10

0.09

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

238

1.07

0.09

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.08

0.09

1.0

2.4

—

4.1

—

(3025315) Body weight

1.08

0.09

8.6

5.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

414

1.05

0.09

1.1

—

61.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.05

0.09

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.05

0.09

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

368

1.05

0.09

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

165

1.09

0.09

4.4

5.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.11

0.09

7.2

4.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.03

0.08

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

677

1.03

0.08

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.80

0.08

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.07

0.08

1.1

1.4

—

(3051651) Icteric interference index of Serum or Plasma

454

1.04

0.08

2.9

3.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

482

1.04

0.08

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.02

0.07

1.0

—

(3025130) Human papilloma virus identified in Specimen

329

0.95

0.07

1.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

1.08

0.07

6.1

4.5

—

(3024932) HLA-DR beta [Type]

0.83

0.07

1.1

—

(3024471) HLA-A [Type]

1.04

0.07

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

231

0.94

0.06

1.4

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

438

1.04

0.06

1.1

—

3.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

566

0.97

0.06

1.5

1.2

4.6

u/ml

0.00

256

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

168

1.07

0.06

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

230

0.95

0.05

2.0

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

124

0.92

0.05

2.2

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

271

1.05

0.05

1.0

1.4

u/ml

—

115

(3027944) Amphetamines [Presence] in Urine

141

1.07

0.05

1.2

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

235

1.05

0.04

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

151

1.07

0.04

1.1

1.2

6.7

3.2

u/l

—

(3047189) Immunofixation for 24 hour Urine

391

0.97

0.04

1.3

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

114

1.08

0.04

2.7

3.0

1.1

0.5

u/field

0.69

114

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

132

0.93

0.04

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

208

1.05

0.03

2.4

1.2

—

(4268621)

370

0.97

0.03

2.7

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

247

2319

1.01

0.03

2.3

2.2

0.0

g/l

0.00

225

2074

(3008401) Mugwort IgE Ab [Units/volume] in Serum

265

1.04

0.03

1.0

0.5

1.2

u/ml

—

108

(3015183) Erythrocyte sedimentation rate

106

1.07

0.02

1.4

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

322

1.03

0.02

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

673

0.98

0.02

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

313

1.03

0.02

1.1

1.0

0.8

u/ml

—

114

(3024928) Oxygen saturation in Venous blood

168

1577

1.01

0.02

2.6

2.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

177

0.96

0.01

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

164

1.04

0.01

2.6

1.2

—

(3011648) Oxygen content in Venous blood

489

0.99

0.01

1.7

1.6

10.9

10.1

0.72

489

(3001729) Color of Synovial fluid

1.06

0.00

1.2

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

157

0.96

0.00

1.8

1.3

105.9

54.4

pmol/l

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

583

0.99

0.00

1.9

1.7

5.4

4.8

mg/l

0.30

541

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

581

1.01

0.00

1.4

1.2

7.1

3.9

u/ml

0.57

177

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

210

0.99

0.00

1.5

1.8

5769.4

21718.9

e6/l

0.99

119

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

468

1.01

0.00

1.8

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

192

0.99

0.00

1.3

1.6

0.5

0.4

ug/l

—

109

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

103

1.01

0.00

11.5

10.7

0.6

mmol/l

0.17

(3045716) Anion gap in Serum or Plasma

365

1.01

0.00

1.9

2.0

8.4

9.1

mmol/l

0.51

280

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

439

0.99

0.00

1.0

1.1

11.4

3.2

u/ml

0.61

(3044007) Cell count panel - Peritoneal fluid

191

0.99

0.00

1.6

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

143

0.99

0.00

1.3

1.4

—

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.98

0.00

1.2

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.93

0.00

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.97

0.00

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.86

0.00

1.8

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

11.2

—

(3009871) Measles virus Ab [Titer] in Serum

0.95

0.00

1.7

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.8

—

5.7

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.01

0.00

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRY_AMD and mortality.

Females

Parameter	HR [95% CI]	p-value
DRY_AMD	0.971 [0.89, 1.06]	0.514
Birth year	0.994 [0.99, 1.0]	0.12

During the follow-up period (1.1.1998 — 31.12.2019), 18068 out of 41213 females with DRY_AMD died.

Males

Parameter	HR [95% CI]	p-value
DRY_AMD	1.016 [0.91, 1.13]	0.779
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 10705 out of 22693 males with DRY_AMD died.

Mortality risk

Mortality risk for people of age

years, who have DRY_AMD.

N-year risk	Females	Males
1	0.089%	0.153%
5	0.571%	1.022%
10	1.375%	2.718%
15	2.611%	5.53%
20	4.548%	9.433%

Relationships between endpoints

↥

Index endpoint: DRY_AMD – Dry age-related macular degeneration (includes geographic atrophy)

GWS hits: 23

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dry age-related macular degeneration (includes geographic atrophy)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints